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 1 
Introduction 
 
 
1.1 Key properties and applications 
 
Formaldehyde [methanal, CAS No. 50-00-0; EC No. 200-001-8] is an organic 
compound with the formula CH2O. At room temperature, it is a gas with a strong 
chemical reactivity (as it is electrophile) and it readily converts to derivative 
compounds. It has a molecular weight of 30.03, and a boiling point of -19°C (Lide, 
2003). Because of its low boiling point it is not considered to belong to the Volatile 
Organic Compounds (VOCs), and is not sampled or analysed with the methods used 
for the VOCs. As the simplest aldehyde, it is a common precursor to many other 
chemicals, especially polymeric compounds.  
Formaldehyde does not accumulate in the environment, because it undergoes 
photolysis within a few hours by sunlight or biologic breakdown by bacteria present in 
soil or water. 
It is generally commercialised as formalin, a colourless aqueous solution, with a 
characteristic pungent odour. Saturated solution of formaldehyde (about 40% by 
volume or 37% by mass) in water, usually contain a small amount of stabilizer (i.e. 
methanol) to limit oxidation and polymerization. 
 
Formaldehyde ranks among leading HPVCs (High Production Volume Chemicals): in 
2004 its production in EU and Norway amounted to 10.7 million tons (FormaCare, 
2008) while world production was reported to be about 21 million tons (IARC, 2006). 
Formaldehyde is one of the most utilised chemical substances in the world as it is a 
common component of a large variety of materials. Because of its high versatility, 
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formaldehyde has application in numerous uses. Thermosetting polymers are resins 
that achieve hardiness through the formation of a 3-D network of bonds (curing 
process). Production of formaldehyde resins accounts for more than half of 
formaldehyde consumption and probably its most significant economic sector. The 
most widespread formaldehyde-based resins are: 
– urea-formaldehyde, 
– melamine-formaldehyde,  
– phenol-formaldehyde; 
 
Formaldehyde-based materials are employed in a huge number of products, in 
particular are basic components of wood-based material such as plywood, 
fibreboard, particle board. They are also present in adhesives, insulating foams, 
glues, automotive equipment, textile treatments, and dozens of other consumer’s 
products. 
 
Formaldehyde is also extensively used as preservative, biocide and disinfectant. 
Formalin is the most common solution to fix and preserve biologic specimens: 
hospitals, laboratories, embalmers consume significant amounts of formalin every 
day. In a more diluted solution, formaldehyde is also present in many household 
products such as detergents, disinfectants and varnishes. 
 
 
 
1.2 Sources of exposure 
 
Formaldehyde emerged as the first modern, non-industrial, indoor air quality issue. 
During 1970’s when concerns about energy efficiency led to efforts to improve home 
insulation, Urea-Formaldehyde Foam Insulation (UFFI) became an important 
insulation product for existing houses. Formaldehyde-based materials have the 
characteristic of slowly releasing molecules of formaldehyde into the environment 
(see figure 1.2 Urea-formaldehyde resin structure) by hydrolysis. Indoor air surveys 
soon detected formaldehyde releases also from chipboards and plywood, both widely 
used in building and furnishing materials.  
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Household products such as detergents and disinfectants are also significant 
domestic sources of formaldehyde; among considerable indoor sources there are 
other consumer products like paints, adhesives, carpets, varnishes, textiles and so 
on. 
Formaldehyde is also a by-product of combustion processes, Environmental Tobacco 
Smoke (ETS) in particular. Air chemistry of terpenes, contained in fragrances and air 
fresheners, which are more and more widespread in domestic settings, can form 
formaldehyde in presence of ozone (even if it is present at levels of ppb) (ECA-IAQ, 
2007).  
Because of its multitude of indoor sources, formaldehyde is found ubiquitously in 
almost all indoor environments at levels which exceed the outdoor concentrations by 
an order of magnitude or more. Background levels of formaldehyde present in 
outdoor air (in rural areas) are usually lower than 10 µg/m3 or 8 ppb.(1 ppb = 1.24 
µg/m3 ). 
Nowadays formaldehyde emissions from wood-based panels have been regulated in 
most developed countries. Typical indoor levels in dwellings and offices are in the 
range of 15÷50 µg/m3 (12-40 ppb), even if in some cases they can reach 
concentrations above 100 µg/m3 (80 ppb) (Kotzias et al, 2005). Higher 
concentrations are found in environments where there is a large presence of wood-
based materials, in brand new, renewed/refurnished environments or in those 
characterised by poor ventilation, high relative humidity and temperature. 
The maximum values measured indoors varied quite a lot since the 1980s, as can be 
seen when comparing the various surveys carried out in Germany (GerES 1985/86) 
to the most recent ones from France (OQAI, Indoor Air Quality Observatory, Kircher 
et al, 2006) and AIRMEX (Kotzias et al, 2009). A trend to decreasing concentration 
over time seems to be observed. This reduction can be partially attributed to the less 
emitting materials being developed over time, in the context of various labelling 
schemes in place in different European countries, including Italy (i.e. class E1, where 
concentrations at equilibrium state must not exceed 0.1 ppm) where have become 
mandatory in 2008. Nevertheless, in spite of the restrictions adopted, formaldehyde 
remains an indoor air quality issue. Due to its widespread diffusion it has been 
recognised as the most critical substance for indoor air quality (Kotzias et al, 2005).  
Though formaldehyde is an indoor air pollutant that has been acknowledged and 
measured broadly for decades across Europe, and considering its large spreading 
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and the concern for human health, representative and accurate data describing 
indoor exposure to formaldehyde in Europe are still scarce.  
 
Figure 1.2.1 Urea-formaldehyde resin 
 
 
Occupational exposure to formaldehyde is principally due to thermal or chemical 
decomposition of formaldehyde-based resins, to the combustion of organic 
compounds, and emission from aqueous solutions (i.e. in laboratories and hospitals). 
Particularly, due to the volatile nature of formaldehyde, the latter is characterised by 
peaks of concentration that can range levels of several ppm if no containment 
measures (i.e. exhaust hood) are put in place (Orsiere et al, 2006). 
 
 
 
1.3 Health effects 
 
1.3.1 Human toxicity 
Being a highly reactive chemical, formaldehyde causes tissue irritation and damage 
on contact. Due to its high volatility, the major and, most significant for human health, 
route of exposure is inhalation, either for indoor or occupational settings. 
Formaldehyde concentrations associated with adverse effects in humans show wide 
inter-individual differences. Predominant symptoms and signs of exposure by 
inhalation in humans are irritation of the eyes, nose and throat, together with 
concentration-dependent discomfort, lacrimation, sneezing, coughing, nausea and 
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dyspnoea. Though oral exposure is rare, formaldehyde ingestion results in severe, 
corrosive, damage to the gastrointestinal tract, followed by CNS depression, 
myocardial depression, circulatory collapse, metabolic acidosis, and multiple organ 
failure (NTP 2010).  
Controlled conditions studies on humans are relatively rare. On the opposite, 
community or work surveys are found very often in scientific literature. Generally, 
these papers do report the air levels of formaldehyde that were associated with 
health symptoms  among people exposed.  
Respiratory tract and eye irritation, and changes in odour threshold, have been 
reported in numerous surveys conducted among general population, even at 
concentration lower than 0.1 ppm. In occupational settings, reported effects include 
allergic contact dermatitis, histopathological abnormalities such as hyperplasia, 
squamous metaplasia, and mild dysplasia of the nasal mucosa, occupational asthma, 
reduced lung function, altered immune response, and hematotoxicity (IARC 2006). 
Some surveys conducted on workers in China suggest that long-term exposure to 
formaldehyde can cause leucopoenia. Particularly, one study reported that a 
significantly higher percentage of formaldehyde-exposed workers had blood cell 
abnormalities (leucopoenia, thrombocytopenia, and depressed serum haemoglobin 
levels) compared to unexposed controls (reviewed by Tang et al. 2009).  
Higher rates of spontaneous abortion and low birth weights have been reported 
among women occupationally exposed to formaldehyde (IARC 2006, Saurel-
Cubizolles et al. 1994).  
Recent literature data highlight the role of recurrent short-term peak exposures, 
rather than exposure to constant formaldehyde levels, in adversely affecting upper 
airways. One study in particular, monitored the health outcomes of a group of 21 
volunteers exposed to several levels of formaldehyde in controlled conditions, with 
and without concentration peaks over a 10-week period, using a repeated exposure 
design (Lang et al., 2008). Eye irritation was found to be the most sensitive 
parameter. Eye and nasal irritation were objectively observed at continuous exposure 
to 0.5 ppm with peaks of 1 ppm exposure, but not at constant exposure to 0.5 ppm. 
Effects reversed 16 hours after the end of the exposures. No significant treatment 
effects of nasal flow and resistance, pulmonary disfunction, and reaction times were 
observed. It was concluded that a No Observed Effect Level (NOEL) for subjective 
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and objective eye irritation is 0.5 ppm in case of constant exposure levels, and 0.3 
ppm with peaks of 0.6 ppm in case of short-term peak exposure.  
Another study performed on asthmatic volunteers in controlled conditions was 
conducted in 2006 to evaluate the influence of pre-exposure to low-dose 
formaldehyde (100 µg/m3, 0.08 ppm, for 30 min) on bronchial response to a mite 
allergen (Casset et al. 2006). Patients developed an immediate bronchial response at 
a significantly lower dose of mite allergen than after fresh air exposure, suggesting 
that formaldehyde might be involved in asthma exacerbation.  
A possible mechanism to explain the association between formaldehyde exposure 
and asthma was proposed by Californian Office of Environmental Health Hazard 
Assessment (OEHHA, 2008). This complex metabolic pathway involves several 
enzymes and molecules as it is shown in Figure 1.3.1.1. In particular, it is 
hypothesised that formaldehyde plays a role in the dis-regulation of nitric oxide (NO), 
and this might help to explain the variety and variability in manifestations following 
formaldehyde inhalation. Further, is believed that genetic variation among individuals 
in the alcohol dehydrogenases affects individual responses to formaldehyde. It is 
concluded that although human studies investigating asthma, atopy or hyper-
sensitisation due to formaldehyde exposure are not entirely consistent with each 
other (and there is a potential for confounding in each), taken together they suggest 
that children may be somehow more sensitive to formaldehyde than adults. 
 
Figure 1.3.1.1 Formaldehyde-dehydrogenase (ADH3) mediated metabolism 
hypothesis (from OEHHA RELs, 2008). 
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1.3.2 Animal toxicity 
The toxic effects of formaldehyde in experimental animals include irritation, 
cytotoxicity, and cell proliferation in the upper respiratory tract, ocular irritation, 
pulmonary hyperactivity, bronchoconstriction, gastrointestinal irritation, and skin 
sensitization. Other reported effects include oxidative stress, neurotoxicity, 
neurobehavioral effects, immunotoxicity, testicular toxicity, and decreased liver, 
thyroid gland, and testis weights (IARC 2006, Aslan et al. 2006, Sarsilmaz et al. 
2007, Golalipour et al. 2008, Özen et al. 2005, Majumder and Kumar 1995).  
Toxicological data from long-term studies seem to prove that irritant effects are 
concentration rather than dose (i.e, concentration x time) depended. Paustenbach 
1997, OEHHA 2008 and others reviewed several chronic and sub-chronic studies on 
animals (Rush et al 1983, Wilmer et al 1989, Woutersen et al 1989), which suggest 
the concentration-dependent nature of irritation and cytotoxicity due to formaldehyde 
exposure. OEHHA deems that No Observed Adverse Effect Levels (NOAELs) and 
Lowest Observed Adverse Effects Levels (LOAELs) are similar in the reviewed 
studies regardless of exposure duration. Also pulmonary functionality was reported to 
be not affected in sub-chronic exposure to formaldehyde concentrations below 2 
ppm.  
Time-effect relationships of formaldehyde concentrations on airways was 
investigated in two studies (Nielsen et al. 1999, Andersen et al. 2008) particularly. In 
the first study (Nielsen et al. 1999), several respiratory parameters in relation to 
formaldehyde exposure were monitored and a NOEL value of 0.3 ppm was found in 
mice, comparing animal to human sensitivity to the substance .  
In a more recent study (Andersen et al, 2008), endpoints considered included 
inflammatory infiltrate, epithelial hyperplasia and genomic signature in rats. 
Inflammatory response was observed starting from 0.7 ppm, while a trend toward 
altered gene expression was observed between 0.7 and 2 ppm.  As regards cell 
proliferation no effect was found below 2 ppm. 
In vitro studies have demonstrated that formaldehyde is directly cytotoxic and affects 
cell viability, cell differentiation and growth, cell proliferation, gene expression, 
membrane integrity, mucociliary action, apoptosis, and thiol and ion homeostasis 
(IARC 2006). Since metabolism of formaldehyde is glutathione-dependent, cells 
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depleted of glutathione are more susceptible to formaldehyde toxicity (Ku and Killings 
1984).  
 
1.3.3 Carcinogenicity 
A large number of epidemiological studies evaluated the relationship between 
formaldehyde exposure and carcinogenicity in humans, revealing an association 
between exposure to formaldehyde and cancer in humans. Findings show increased 
risks of nasopharyngeal cancer, sinonasal cancer, and myeloid leukemia among 
individuals with higher exposure to formaldehyde (either exposure level or duration), 
which could not be explained by chance, bias, or confounding factors.  
An increased risk for nasopharyngeal cancer was found among individuals with the 
highest formaldehyde exposure in numerous case-control studies (Vaughan et al. 
1986, 2000, Roush et al. 1987, West et al. 1993, Hildesheim et al. 2001). Excess 
nasopharyngeal cancer mortality associated with formaldehyde exposure was 
observed in the US National Cancer Institute (NCI) cohort of industrial workers 
(Hauptmann et al. 2004). Further, positive exposure-response relationships were 
found both in a large multi-centre case-control study (Vaughan et al. 2000) and in the 
NCI cohort (Hauptmann et al. 2004).  
Concerning sinonasal cancer, an increased risk was found in population-based case-
control studies (Olsen et al. 1984, Olsen and Asnaes 1986, Hayes et al. 1986, Roush 
et al. 1987, Luce et al. 1993). A pooled analysis of 12 case-control studies (Luce et 
al. 2002) found also an excess of sinonasal cancer. In most studies, estimates of 
increased risk for both sinonasal adenocarcinoma and squamous-cell carcinoma; 
were statistically significant for individuals ever exposed to formaldehyde, or with 
higher probability or higher levels of exposure.  
An association between excess mortality from leukemia or combined 
lymphohematopoietic cancers has been reported in several cohort studies, including 
studies of professional groups (especially embalmers) and some of the studies of 
industrial cohorts (NTP 2010). Some of these studies reported positive exposure-
response relationships for combined lymphohematopoietic cancer or specific 
subtypes (Beane Freeman et al. 2009, Hauptmann et al. 2009). In particular, the 
strongest associations were observed for myeloid leukemia. The most informative 
studies for evaluation of the risk of this cancer are the large cohort studies (NCI, 
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NIOSH, British cohorts) of industrial workers and the NCI nested case-control study 
of lymphohematopoietic cancer in embalmers. Three of these (NCI, NIOSH and 
embalmers), found elevated risks of myeloid leukemia among individuals with high 
exposure to formaldehyde, as well as positive exposure-response relationships 
(Beane Freeman et al. 2009, Pinkerton et al. 2004, Hauptmann et al. 2009). In 
contrast, no association between these types of cancer was found among British 
chemical workers cohort (Coggon et al, 2003). Exposure to peak levels of 
formaldehyde (of 4 ppm and above) was associated with increased mortality of 
lymphohematopoietic cancers among workers in the NCI cohort study (Beane 
Freeman et al. 2009), while no associations were found with cumulative or average 
exposure. In the smaller industrial cohort studies, some reported excesses for all 
lymphohematopoietic cancers combined among formaldehyde-exposed workers 
(Bertazzi et al. 1989, Stellman et al. 1998) or leukemia (Hansen and Olsen 1995, 
1996), but others observed no association for all lymphohematopoietic cancers 
combined (Andjelkovich et al. 1995, Stern 2003, Pinkerton et al. 2004) or leukemia 
(Andjelkovich et al. 1995, Stellman et al. 1998, Stern 2003). With respect to other 
case-control studies, a population-based study found no clear association between 
leukemia and exposure to formaldehyde (Blair et al. 2001), and two nested case-
control studies reported statistically non-significant increases in leukemia risk based 
on small numbers of exposed cases (Partanen et al. 1993, Ott et al. 1989).  
 
Formaldehyde has been tested for carcinogenicity in mice, rats, and hamsters. 
Studies reviewed include chronic and sub-chronic inhalation studies in mice, rats, 
and hamsters; chronic and subchronic drinking-water studies in rats; and one 
chronic skin-application study in mice (NTP. 2010). 
Long-term exposure inhalation to formaldehyde by inhalation caused nasal tumours, 
both benign (polypoid adenoma) and malignant (predominantly squamous-cell 
carcinoma but also adenocarcinoma and carcinoma) in male and female F344 rats 
(Kerns et al. 1983, Monticello et al. 1996, Kamata et al. 1997), male Sprague-Dawley 
rats (Sellakumar et al. 1985), and male B6C3F1 mice (Kerns et al. 1983a). In 
particular, long-term exposure to 6 ppm formaldehyde and above caused squamous 
cell carcinomas of the nasal cavity of rats with a non-linear, biphasic concentration-
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response relationship having the breakpoint at or above 2 ppm. (Kerns et al 1983, 
Monticello et al. 1996). 
Nasal tumours were observed after 13 weeks exposure in male Wistar rats also 
(Feron et al. 1988). Although the increased incidences of nasal tumours in mice and 
in the short term exposure study in rats were not statistically significant, they were 
considered to be biologically significant because of the rarity of this type of tumour.  
 
One of the most accredited hypotheses to date explaining carcinogenic pathway has 
been based primarily upon data derived from laboratory studies. Increased cellular 
proliferation, as a consequence of epithelial cell toxicity, appears to be the most 
significant determinant of tumour progression associated with formaldehyde 
inhalation. Formaldehyde concentration, rather than duration of exposure, seems to 
be related to histopathological effects and increased proliferation of epithelial 
respiratory cell in the nasal cavity. Further, the extent of proliferative response 
depends on the specific site of the nasal cavity being examined (Liteplo and Meek, 
2003). These regions are similar to those where tumours are observed. Significant 
increases in endpoint considered such as cytotoxicity, increased epithelial cell 
proliferation, and even DNA-cross linking, though non-linear, are observed at 
concentration of 4 ppm (Casanova & Heck, 1987). This might be correlated with the 
concentration at which mucociliary clearance is inhibited (> 2 ppm ca.) and 
gluthatione-mediated metabolism saturated (4 ppm) (Morgan et al, 1986a, Casanova 
et al, 1994). 
Several studies consider formaldehyde exposure associated with multiple modes of 
action related to carcinogenicity, such as DNA reactivity, gene mutation, 
chromosomal breakage, aneuploidy, epigenetic effects (binding to lysine residues of 
histones), glutathione depletion, oxidative stress, and cytotoxicity-induced cellular 
proliferation (Lu et al. 2008, Guyton et al. 2009, NTP 2010). Although an evidence for 
a genotoxic mode of action for formaldehyde-induced cancer seems possible, the 
mechanisms by which formaldehyde causes cancer are not completely understood. 
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1.4 Classification  
 
Formaldehyde classification, especially concerning carcinogenicity, presents relevant 
discrepancies among different countries.  
 
1.4.1 European Union 
In EU, accordingly to Directive EEC/67/548, it is classified as Carcinogen Category 3. 
This group includes “substances which cause concern for man owing to possible 
carcinogenic effects but in respect of which the available information is not adequate 
for making a satisfactory assessment. There is some evidence from appropriate 
animal studies, but this is insufficient to place the substance in Category 2”. This 
means that ‘there is a limited evidence of carcinogenic effect’. Further, is classified as 
Toxic (T) and Corrosive (C), and the following Risk and Safety Phrases are given: 
 R23/24/25 : Toxic by inhalation, in contact with skin and if swallowed. 
 R34 : Causes burns.  
 R40 : Limited evidence of a carcinogenic effect.  
 R43 : May cause sensitization by skin contact.  
• S1/2 : Keep locked up and out of the reach of children.  
• S26 : In case of contact with eyes, rinse immediately with plenty of water and 
seek medical advice.  
• S36/37/39 : Wear suitable protective clothing, gloves and eye/face protection.  
• S45 : In case of accident or if you feel unwell, seek medical advice 
immediately (show the label where possible). 
• S51 : Use only in well-ventilated areas.  
Regarding chemical safety, due to its low flash point, it is classified as a flammable 
gas. 
Classification of its commercialised products depends on concentration range. In 
table 1.4.1 specific concentration limits are reported. 
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Table 1.4.1.1 Concentration limits for formaldehyde classification (67/548/CEE) 
Concentration ranges Classification 
 
C ≥25 % 
 
T, C; 
R23/24/25-34-40-43 
 
5 % ≤ C < 25 % 
 
Xn; 
R20/21/22-36/37/38-40-43 
 
1 % ≤ C < 5 % 
 
Xn; 
R40-43 
 
0,2 % ≤ C < 1 % 
 
Xi; 
R43 
 
New CLP Regulation (Reg. (EC) No. 1272/2008 on Classification, Labelling and 
Packaging) does not produce substantial differences in classification from Dir. 
EEC/67/548. Concerning carcinogenicity, formaldehyde is listed in Group 2 
(“suspected human carcinogen”).  
 
Already in 2005, France proposed to classify formaldehyde as Category 1 
carcinogen, with the phrase R49 “can cause cancer if inhaled”. In spite of this, the 
European Chemicals Bureau, did not reach a decision to change the classification at 
that time. Recently this year (September 2010), French government advanced a 
reclassification proposal, supported by a dossier submitted to the European 
Chemicals Agency (ECHA), requesting its upgrading among Category 1 carcinogens. 
According to ECHA, the dossier is currently being processed. If the accordance 
check is fulfilled and it is accepted by the Member State Committee (MSC) for 
consideration, a public consultation could start by the end of the year or early 2011. A 
category 1 or 2 classification under the Dir. EEC/67/548, or a 1A or 1B classification 
under CLP, would have significant implications for use of formaldehyde. In fact, as a 
consequence of a potential reclassification, also formaldehyde inclusion in REACH 
Annex XV (list of substances subject to authorisation), is to be considered a likely 
outcome. 
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As regards other aspects of REACH Regulation it is not considered “Persistent 
Bioaccumulating Toxic (PBT)” or “very Persistent very Bioaccumulating (vPvB)” 
substance, while being a High Production Volume Chemical (HPVC) its deadline for 
REACH registration is 30th November 2010 (its dossier has already been submitted). 
 
Formaldehyde is not listed in the Annex I of Regulation (EC) No 689/2008 (export 
and import of dangerous chemicals regulation), nor on a priority list for risk 
assessment. However, formaldehyde is banned from use in certain applications 
(preservatives for liquid-cooling and processing systems, slimicides, metalworking-
fluid preservatives, and antifouling products) under the Biocidal Products Directive 
(Directive 98/8/EC).  
 
1.4.2 IARC and US classification 
In 2004, based on observed excess risk of nasopharyngeal cancers in the 
considered cohorts, the International Agency for Cancer Research (IARC) 
reclassified formaldehyde as carcinogen to humans in Group 1 (Cogliano, 2005, 
IARC 2006). In October 2009, IARC concluded on the basis of the outcomes from 
cohort studies, that there is sufficient evidence for a causal association between 
formaldehyde and leukemia. 
 
Outside EU, other re-considerations of formaldehyde classification regarding 
carcinogenicity have taken place in last year. In particular, in United Stated, on 
January 2010 the Department of Health and Human Service re-classified 
formaldehyde from “reasonably anticipated to be a human carcinogen” to ‘known 
human carcinogen’ through its National Toxicology Program (NTP).  
In addition, last June, the US Environmental Protection Agency (US EPA) released 
for public consultation a draft report wherein it is affirmed that sufficient 
epidemiological evidence to consider formaldehyde ‘carcinogenic to humans by the 
inhalation route of exposure’ both exists for naso-pharyngeal and lympho-
hematopoietic cancers. Public consultation was expected to be closed within 3 
months (September 2010), nevertheless, no news has been posted on EPA website 
to date (November 2010). Currently, official EPA classification regarding 
carcinogenicity is B1, “probable carcinogen”. 
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1.5 Project objectives 
 
The project has been developed around two major purposes.  
The first one has been to perform a hazard characterisation of formaldehyde in order 
to calculate health-based reference exposure limits for concentrations in indoor air. 
This study has been carried out participating at European Project “INDEX UPRIC 
2009” funded by DG SANCO. 
The first edition of the project INDEX “Critical Appraisal of the Setting and 
Implementation of Indoor Exposure Limits in the EU”, funded by DG SANCO in 2004, 
aimed to perform risk assessments for several pollutants typical of indoor 
environments and the proposal of reference limit of exposure and/or risk 
management measures (Kotzias et al, 2005). Outcomes have contributed to the 
development of strategies at EU level for indoor air quality management. In 2009, DG 
SANCO re-funded an update of the project, with particular regards to formaldehyde. 
INDEX-UPRIC (UPdate of PRIority compounds) aimed to review recent scientific 
data in order to re-consider reference values proposed in 2005. From selected results 
of scientific literature and an innovative approach in uncertainty factors application, 
new reference limits have been calculated for formaldehyde in indoor settings and 
proposed at EU level. 
The second objective of the project has based its rationale from the outcomes of 
INDEX project. From the hazard characterisation of formaldehyde, it seems that 
recurrent, short-term, peak exposures, rather than exposure to constant levels, are 
expected to adversely affect eyes and upper airways in exposed subjects. Secondly, 
exposure to formaldehyde in occupational settings, and particularly in Pathology labs, 
seems to be characterised by marked fluctuations and peaks of concentration. To 
perform a correct exposure assessment in Pathology Units, and to eventually 
associate exposure levels with health effects, an in-depth understanding of exposure 
is a requirement. The project aimed to reach this goal through the development of 
detailed Exposure Scenarios and the comprehension of concentration fluctuations 
during specific tasks in Pathology Units of two different hospitals. 
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Materials and  
Methods 
 
 
2.1  European Project INDEX-UPRIC 2009 
2.1.1  Literature review 
An extensive literature review of the period 2004-2009 about crucial topics regarding 
formaldehyde has been carried out. Also relevant previous studies and reviews were 
reconsidered. Data have been searched for formaldehyde exposure (especially on 
community surveys) and health effects by inhalation (both on volunteers and 
animals). Epidemiological data concerning carcinogenicity have been taken into 
account as well. A particular attention has been paid to reports published by national 
or international institutions. Due to their use for risk assessment and for exposure 
limits calculation by several institutions, surveys at the workplace have been carefully 
evaluated. 
Web search of scientific papers about formaldehyde health outcomes and cohort 
studies has been based mostly on digital archives PubMed and Web of Science. Key 
words of the search have been  “formaldehyde toxicology”, “formaldehyde irritation”, 
“formaldehyde effects”, “formaldehyde asthma” and “formaldehyde cohort”. To seek 
for exposure levels among population both above-mentioned archives and Google 
have been used. Key words have been “formaldehyde surveys”, “formaldehyde 
exposure”, “and formaldehyde indoor”. Web sites of major national and international 
organisations have been consulted looking for reports, evaluations, if present, the 
classification proposed and any other relevant news or communication on 
formaldehyde. Workplace surveys have been initially identified from the bibliography 
of organisation reports; further the search has deepened following usual scientific
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 archives cited above with key words “formaldehyde work exposure” and 
“formaldehyde monitoring”. Also a number of in-silico studies have been considered, 
since when their significance appeared from the literature review.  
Following the search, relevant literature has been catalogued. International 
organisation guidelines together with scientific reviews and risk evaluations have 
been separately summarised by: 
 health outcome:  
o toxicological effect except cancer and  
o carcinogenicity;  
 setting: 
o indoor (home, kindergarten or office) or 
o occupational. 
 
Relevant scientific papers such as human, animal and in-silico studies have been 
arranged by condition (controlled or uncontrolled exposure) and by outcomes: 
 
 health effect on humans, excluding carcinogenicity: 
o subjective discomfort, 
o signs of irritation of eyes and upper airways,  
o pulmonary function,  
o occurrence of asthma or hypersensitivity (hyperreactive airways?), 
o genotoxicity; 
o histopathological changes; 
 
 health effect on animals, excluding carcinogenicity: 
o histopathological/biochemical changes in nasal tissues, 
o pulmonary function, 
o genomic signature; 
 
 In-silico studies. 
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2.1.2 Calculation of reference exposure values 
The derivation of reference exposure values has been based on recent human and 
animal studies. The choice of pivotal studies has been based on the following 
parameters.  
First, the study must have been conducted under well defined and controlled 
conditions, especially with respect to air concentrations of formaldehyde and length 
of exposure (via inhalation. Second, health outcomes investigated have to be 
unequivocally attributed to formaldehyde exposure, to be extensively documented, 
and to occur at low levels of exposure (most sensitive endpoint).  
The endpoint chosen was irritation of eyes (in humans) or upper airways, especially 
nose tissues (in animals). Eye irritation in humans has been measured with two 
parameters, conjunctival redness and eye blinking frequency (Lang et al, 2008). 
Irritation of upper airways is deemed to be due to sensory irritation caused by the 
direct stimulation of the trigeminal nerve endings of the upper respiratory tract. This 
effect is measured as the decreases in respiratory rate in mice (Nielsen et al, 1999). 
In rats irritation signs have been identified as inflammatory infiltrates development at 
various nasal tissues (Andersen et al, 2008). 
 
Based on these criteria, two animal (on mice and rats) and one human study have 
been chosen for formaldehyde hazard assessment (characterisation) 
To calculate reference exposure values, chemical-specific uncertainty factors (also 
known as assessment factors) have been applied as described in a document 
published by World Health Organization International Programme on Chemical 
Safety (IPCS, 2006) to toxicological endpoint values such as NOAELs or LOAELs. 
This report present several indications for the use of adjustment or uncertainty factors 
in the calculation of health-base exposure limits for chemical substances. It 
distinguishes and assigns different weights to toxicokinetic and toxicodynamic 
components. As depicted in figure 2.1.3.1, the default uncertainty factor used to set 
exposure limits for general population accounts for both inter-species (factor of 10) 
and inter-individual differences (factor of 10) evenly. Here specific weights are given 
for the toxicodynamic and toxicokinetic components, accounting for inter-species or 
inter-individual variability.  
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Figure 2.1.2.1 Different weights for toxicokinetic and toxicodynamic components from 
WHO, Harmonisation Project Document No. 2, 2005. 
 
 
 
 
 
 
Further, warnings are given on the nature of chemical. Particularly, a Chemical 
Specific Assessment Factor (CSAF) should be applied, and has to be determined by 
the chemical-specific data. It is reported that “an inter-species factor could be less 
than 1 if humans had lower target tissue exposure to the active chemical moiety for 
the same external dose or showed lower tissue sensitivity”.  
Default UNCERTAINTY FACTOR 
for general population: 100 
INTER-SPECIES DIFFERENCES 
10 
INTERINDIVIDUAL DIFFERENCES 
10 
TOXICO- 
DYNAMIC 
2.5 
TOXICO- 
KINETIC 
4.0 
 
TOXICO- 
KINETIC 
3.16 
TOXICO- 
DYNAMIC 
3.16 
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2.2 Exposure characterisation and scenarios in hospitals 
 
2.2.1 Identification of uses and exposure determinants 
Exposure characterisation of formaldehyde in a Pathology Unit has started from the 
building of Exposure Scenarios. An Exposure Scenario is “a set of information 
describing the conditions under which the risks associated with the identified use(s) 
of a substance can be controlled. It includes operational conditions (for example the 
duration and frequency of use or the amount used, the process temperature or the 
pH) and necessary risk management measures (e.g. local exhaust ventilation or a 
certain type of glove, waste water and waste gas treatment)”. It is an iterative process 
which is part of the Chemical Safety Assessment (CSA) under REACH Regulation. In 
particular, the preparation of Exposure Scenarios is mandatory for the registration 
when a substance is manufactured or imported in quantities of 10 tonnes per year 
and above and classified as dangerous or as PBT (Persistent Bioaccumulative Toxic) 
or vPvB (very Persistent very Bioaccumulative). Relevant exposure scenarios will be 
annexed to the Safety Data Sheets that will be supplied to downstream users and 
distributors. 
This part of the work has been based on REACH Regulation Technical Guidance, 
particularly on the document “Guidance on information requirements and chemical 
safety assessment - Part D: Exposure Scenario Building” (ECHA, 2008). 
The two hospitals chosen for the purpose are located on the territory of the 
municipality of Milan. Pathology Units presents differences in size, number of 
operators occupied, instruments and organisation adopted. Nevertheless, the same 
checklist (based on REACH technical guidance) has been applied during interviews 
with personnel (pathologists, students, technicians and other attendants).  
At first, uses of formalin within the unit have been identified: all direct tasks, which 
involve the handling of formalin (i.e. inclusion of specimens in formalin, dilution, 
disposal, etc) and indirect, which do not bring the operator to the direct handling of 
formalin (i.e. colouration, inclusion in paraffin, etc) have been recognised from 
dilution, to its disposal. For each one of them a description of the activity is given and, 
when possible, of exposure determinants such as concentration, frequency, quantity, 
duration, existent mitigation measures (i.e. ventilation, extracting devices or chemical 
hood) and observations noted during the first inspection. Further, each room 
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interested by the use of formalin has been numbered. The checklist headlines are 
reported in table 2.2.1.1. 
Based on the exposure determinants and conditions of use, it has been possible to 
identify some uses as critical for operator exposure. Particular attention has been 
paid to those tasks in which there is a direct use of formalin. In fact, the monitoring 
survey has been planned to measure air concentrations during selected, critical 
tasks, where possible one by one, trying to avoid overlapping. In such a way, air 
levels of formaldehyde and their fluctuations can be better understood and 
associated to single tasks.  
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Table 2.2.1.1 Checklist for identification of formalin uses and other exposure determinants in Pathology Units. 
 
Task Description Environment Concentration Quantity Frequency Duration 
Existing 
mitigation 
measures 
Observation 
during 
inspection 
Air 
monitoring: 
necessary? 
Air monitoring 
technique chosen 
Task 1 Brief  
description 
of the 
operation 
Room No # % v/v or m/v of 
active substance 
Volume used (if 
not possible give 
an approximate 
estimation) 
Say if the task 
is performed 
daily/ # times 
per week. 
Seconds/minutes/ 
hours. 
Ventilation or 
exhaust 
extraction 
(aspirated bench, 
chemical hood) 
Report any 
peculiarity. 
Yes/No Passive/Active/In-
continuous/all of 
them 
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2.2.2 Air monitoring techniques 
The air sampling techniques measuring formaldehyde are crucial to perform an 
Exposure Characterisation. To date, traditional air monitoring for the measurement of 
formaldehyde levels, have been mostly conducted using both active and passive 
devices. Those methods can provide air concentrations as Time Weighted Average 
(TWA), over 15-20 minutes with active devices and over hours to days when using 
passive techniques. Thus, traditional air monitoring may not be able to identify short-
term concentration fluctuations typical of pathology labs. In-continuous gas sampler 
could present an effective method to depict formaldehyde fluctuations and peaks in 
laboratories. To conduct a detailed monitoring and to assess the suitability of different 
sampling methods, a simultaneous air monitoring utilising three techniques has been 
planned. 
Since the beginning of the project, the use of a sampling method capable to depict 
the extent of concentration peaks and exposure variability has been taken into 
account. To do this, a brief literature search has been carried out, and some 
companies have been consulted. Three detection techniques have been carefully 
considered: Photo-acoustic gas monitor, infrared sampler, electro-chemical cells. The 
latter has been considered at first, but it has been discounted due to the difficulties in 
device calibration. Bruel Kjaer 1302 photo-acoustic gas monitor (following Photo-
acoustic) has then been chosen. It presents several remarkable characteristics. It is a 
quantitative gas analyser, controlled by a microprocessor, and it works as in-
continuous detector for several gases (depending on the filters chosen). It gives real 
time concentrations within 120 seconds or less, thus it is very likeable to detect peak 
levels. The measurement is based on the principle of photo-acoustic/infra-red 
detection method, in particular on the capability of the molecules to absorb energy as 
infra-red light and release it in the form of heat (with vibrational motions). An air 
sample is drawn and sealed into an analysis cell inside the instrument. The light 
produced passes through an optic filter, which selects the proper wave length to be 
transmitted to the cell. One single wave length is thus transmitted at a given instant. 
When the light emitted is absorbed, selectively, by the gas, its temperature rises. As 
the light is pulsing, gas temperature rises and decreases causing a pressure 
variation. Therefore, an acoustic signal proportional to the gas concentration is 
produced. Two microphones are present inside the cell to detect the signal. When a 
certain gas measuring is done, a rotation of the whirl on which filters are fixed occurs 
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and a new measure can start. It takes about 2 minutes to measure 5 different gases 
and aqueous vapour in the same air sample. Further, Photo-acoustic is calibrated to 
compensate some potential interferences between different compounds (i.e. 
formaldehyde and methanol). Output data (air concentrations) are immediately 
visualised on the display. Data can also be memorised, send to a printer, or 
transferred into a text file ASCII (to be imported in a spreadsheet for elaboration). 
The range of concentrations that can be measured is very wide, from 0.04 to 10 ppm 
(calibrating range). 
 
Figure 2.2.2.1 In-continuous gas sampler: Bruel Kjaer Photo-acoustic monitor 1302 
 
 
 
 
 
 
 
 
Many methods either active or passive have been evaluated to understand their 
suitability to the project objectives. Well known methods such Radiello® for passive 
and DinitroPhenylHydrazine (LpDNPH) cartridges for active monitoring have been 
initially considered, then discarded because alternative, more fit-to-purpose 
techniques have been identified. 
Dräger Bio-check F, colorimetric disposable samplers have been chosen for passive 
air sampling. This method gives a two-hours TWA, meaning that the measure of 
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formaldehyde takes two hours once the device is activated. The principle of this 
simple sampler is an enzymatic reaction, which produces a coloration of the 
substrate in presence of formaldehyde. In this way the reading is semi-quantitative 
according to concentration ranges as reported in table 2.2.2.1. 
 
Table 2.2.2.1 Dräger Bio-check F concentration ranges in ppm* 
 
A B C D E 
≤ 0.05 0.05 - 0.1 0.1 - 0.2 0.2 - 0.3 ≥ 0.3** 
*Part per million; 1 ppm = 1.24 mg/m3 (20°C; 1atm) 
**TLV (US ACGIH) 
 
 
Figures 2.2.2.2a and b. Passive sampler Dräger Bio-check F  
 
 
Among active methods, Dräger CMS (Chip Measurement System) has been chosen 
for its easiness to be transported and moved while monitoring, and for its capability to 
give an immediate response (no need of lab analysis). It is a robust air sampling 
device based on photochemical spectrometry. It composed by three main parts:  
-pump for active sampling; 
-chip, containing 10 micro-vials. Each micro-vial contains micro-granules which will 
be soaked by the chemical reagent; 
-analyser. 
When a connection has been established between incoming gas and conduction 
system a micro-vial is open and the gas is pushed inside by a special inside pump. 
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The range of concentration measured, even if not so wide, is typical of levels 
detected in laboratories (0.2 to 5 ppm). Measuring time varies from about 4 to 12 
minutes depending on the concentration (short-term measurements). Being not 
possible to fix automatically an interval of measurement, a constant surveillance and 
a manual activation are needed. 
 
Figures 2.2.2.3a and b. Active sampler Dräger CMS and chip containing 10 micro-
vials. 
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2.2.3 Monitoring campaigns setting 
 
Preliminary screening 
A preliminary monitoring survey has been conducted at University Hospital Luigi 
Sacco. This survey had the purpose to inspect the labs, to interview the personnel 
and identify tasks and exposure determinants. It included also a preparatory 
screening of formaldehyde concentration by ambient and personal sampling. Dräger 
Bio-check F passive sampler has been used to detect two-hours TWA in three 
rooms: dissection room, central laboratory (where various operations occur) and the 
archive located in the basement. 
 
Exposure modeling exercise 
Before starting with monitoring campaigns, exposure estimation has been carried out 
utilising the software ConsExpo 4.1 (see description in Appendix A). Input data 
inserted try to simulate a plausible routine task which could be pouring a certain 
amount of formalin from a container in dissection room. Results of the exposure 
estimation have been then compared with level of formaldehyde measured in 
laboratories, in particular with those found in dissection room of University Hospital L. 
Sacco. Input data and outcomes of the exercise have been reported in Appendix A. 
 
Testing of the three techniques 
Before starting the paired monitoring with the three techniques, an experiment has 
been conducted in order to test the three instruments during the same situation. The 
test consisted in measuring environmental levels of formaldehyde following formalin 
pouring into an exposure room. It has been conducted in a laboratory provided with 
two chemical extraction hoods. The first one has been sealed with plastic paper and 
kept switched off to work as exposure room; the other one has been switched on in 
order to ensure safe conditions in the lab. Environmental conditions, i.e. ventilation 
and temperature, have been kept under control until the test ended.  
A known amount of formalin (4% m/v formaldehyde) has been poured on filter paper 
in a container under an extraction hood used as exposure room. Another chemical 
extraction hood was switched on in order to ensure safe conditions in the lab.  
Photo-acoustic, CMS and Bio-check F samplers have been placed inside the 
exposure room and started monitoring air concentrations. Formaldehyde levels were 
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expected to follow the dilution model described in the formula below (Clausen et al, 
1993). 
 
 
 
 
 
Where: 
A: (area of emitting surface) [m2] 
M0: (initial mass) [mg]; 
k1= emission rate [m2/m3]; 
k2: air exchange rate [1/t]; 
V: room volume [m3]. 
Data detected by photo-acoustic method fit a decay model (see Appendix B). As 
expected CMS and Bio-check F samplers, gave TWA results, and were in good 
accordance with photo-acoustic measurements. 
During this test a problem with CMS sampler has come out. Some chips were not 
able to read the ‘blank’, namely concentration below detection limit (0.2 ppm). In a 
“control” room, where exposure to formaldehyde levels are expected to be 
exceedingly low, values higher than 0.2 ppm have been measured, a sort of “false 
positive”. The supplier consulted deemed that it must have been a single chip rather 
than a whole apparatus problem.  
Thus, to guarantee a sound use of the instrument and reliable results a method for 
chip selection has been set up. Prior to be used for monitoring purposes, at least 
blank reading for 2 vials each chip (on 10 vials) is required. Chips which gave one 
false positive have been discarded.  
 
Monitoring surveys 
Two monitoring surveys have been planned in the two hospitals. Taking into account 
exposure determinants, tasks identified as critical have been selected for the 
monitoring with the three techniques. Other tasks or situation not expected to present 
high exposure levels have generally been monitored with passive sampler Bio-check 
F only. The careful surveillance of the operation during the measurement has 
permitted to notice and record any peculiar circumstance as well as potential 
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misuses, or even accidental situation (i.e. pouring formalin on the floor or on the 
bench). Concentrations detected have then been compared to the Threshold Limit 
Value (TLV) for occupational exposure to formaldehyde adopted by the American 
Conference of Industrial Hygienists (ACGIH). A detailed Exposure Scenario for each 
use identified as critical, namely those tasks where concentrations clearly exceeded 
TLV-C (or at least for some of them taken together), has been built up and Risk 
Management Measures (RMMs) addressed specifically. 
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2.2.4 Data elaboration 
Principle Component Analysis (PCA) has been used as an exercise on data obtained 
from the survey carried out at the University Hospital L. Sacco. Data from the 
monitoring at National Cancer Institute had a surplus of non-parallel measurements, 
rendering this type of analysis unreliable because of the poor level of variability of the 
data. The statistical unit used in the PCA data matrix has been the timing of 
measurement (sampling) by the three techniques. Only time units having all three 
measures have been analysed.  
The aim of the PCA has been twofold: (a) to investigate the correlation among the 
outputs given by the three sampling methods and, (b) to see the profiles obtained for 
the three sampling techniques per task type. Bio-check F classes have been 
assigned as quantitative values, choosing representative values of 0.075 ppm for 
class B, 0.25 ppm for class D and 0.3 ppm for class E.  
Data obtained with CMS and Bio-check F methods have been paired to each 
measurement obtained with Photo-acoustic. The PCA has then been applied to the 
matrix of the differences between measures and the ACGIH TLV set for 
formaldehyde. The graphical display chosen has been the biplot, in which the x and y 
axes are a linear combination of the three measurements and the vectors reflect the 
behaviour of the original values in the new orthogonal axes. The origin represents the 
TLV. Each point is a bi-dimensional representation of one moment in time, when 
measurements have been taken while a certain task was performed. Each task has 
been given a number that was used to label the points and this allowed comparisons 
of measurements according to task by projecting the single point onto the vectors. In 
fact, when the barycentre of each group of tasks is projected onto the vectors, the 
average profile of the task is obtained. Charts and outcomes are reported and 
discussed in Appendix C. The software used for the analysis has been XLSTAT 
Version 2010.5.08 - Copyright Addinsoft 1995-2010.  
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Results 
 
 
3.1 European Project INDEX-UPRIC 2009 
 
3.1.1 Levels of exposure among general population 
Results of the indoor air formaldehyde measurements in 21 studies representing 
mostly Europe but including also North America, Australia and Japan are 
summarised in Table 3.1.1.1. 
Between 2003 and 2005 the French Observatory on indoor air quality (OQAI) carried 
out a large monitoring survey in 567 dwellings randomly selected (Kirchner et al, 
2006). Formaldehyde median indoor concentration, 95th percentile and maximum 
value of 7-day passive sampling in the bedroom (n=554) were respectively 19.6, 46.7 
and 86.3 µg/m3 (15.8, 37.7 and 69.6 ppb respectively). Still in France, aldehyde 
concentrations were measured through active sampling (duration of measuring varied 
from 30 to 95 min) in 162 homes in the Strasbourg area, in the frame of a case-
control study pairing asthmatic and non-asthmatic people (Marchand et al, 2008). 
Measured formaldehyde mean indoor concentration was 32.2 ± 14.6 µg/m3 (26 ± 
11.8 ppb). 
In Germany, children’s bedrooms in 555 dwellings located in 150 cities were 
monitored by passive sampling during one week, between May 2003 and May 2006 
(KUS, 2008). The geometric mean, the 95th percentile and the maximum value of 
formaldehyde indoor concentration, (n=586) were respectively 23.3, 47.7 and 68.9 
µg/m3 (18.8, 38.5 and 55.6 ppb). These levels were lower than the respective 
concentrations measured in the past years in the frame of the German Environmental 
Survey (GerES I 1985/86). 
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In Belgium, a measuring survey was carried out in 50 dwellings in the frame of the 
FLIES project (Flanders Indoor Exposure Survey) in January and February 2006 
(VITO, 2007). Indoor formaldehyde mean concentrations in bedrooms and living 
rooms were 35, 37 and 21 µg/m3 (28.2, 29.8 and 16.9 ppb) in urban areas, hot spots 
and rural areas respectively. 
 
Much less information is available for formaldehyde levels in offices compared to 
residential settings. A large monitoring survey in offices was carried out in Germany 
between 2001 and 2004 in 419 rooms: a median indoor concentration of 28 µg/m3 
(22.6 ppb) was measured (BGIA, 2004). Over the period 2004-2007, the Joint 
Research Centre of the EC carried out the monitoring of priority pollutants for indoor 
air quality, including formaldehyde within the frame of the Indoor Air Monitoring and 
Exposure Assessment Project (AIRMEX) (Kotzias et al, 2009). The survey included 
monitoring in European public buildings and environments where children frequently 
stay, like schools and kindergartens. Formaldehyde concentrations in offices of public 
buildings (n=94) ranged from 3 to 33 µg/m3 (from 2.4 to 26.6 ppb).  
 
Measurements of formaldehyde indoor levels in schools and kindergartens in many 
European countries are available. In France, in the frame of the study ISAAC 
(International Study on Asthma and Allergies in Childhood), formaldehyde was 
measured in 401 classrooms of 108 schools located in six cities in 1999 (Strasbourg, 
Creteil, Reims, Marseille, Bordeaux, Clermont-Ferrand) (Annesi-Maesano et al, 
2001). Concentrations ranged from 4 to 100 µg/m3 (from 3.2 to 80.6 ppb) with a 
mean value of 27 µg/m3 (21.8 ppb). In 50 Parisian kindergartens studied between 
1999 and 2001, both in winter and summer seasons (n=222), indoor formaldehyde 
concentrations ranged from 1.5 to 56 µg/m3 (from 1.2 to 45.2 ppb) with a median 
value equal to 14 µg/m3 (11.3 ppb) (Domsic and Squinazi, 2001). In Strasbourg, 
formaldehyde concentrations have been measured through passive sampling during 
48h in 111 schools (n=384 classrooms) and 33 day-care centres (n=142 rooms) 
between November 2004 and January 2005 (ASPA, 2005). Mean indoor 
formaldehyde concentrations were respectively 27 µg/m3 (21.8 ppb) in primary 
schools, 22 µg/m3 (17.8 ppb) in elementary schools, and 18 µg/m3 (14.5 ppb) in day-
care centres. Similarly, in the Rhône-Alpes region, formaldehyde concentrations have 
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been measured by passive samplers during 4,5 days in 28 schools and 22 day-care 
centres (n=150 rooms) between June 2006 and March 2007 (Rhône-Alpes, 2007). 
Mean indoor formaldehyde concentration was higher in schools than in day-care 
centres 24.1µg/m3 (19.4 ppb) versus 18.6 µg/m3 (15 ppb). 
In Germany, in the region of South Bavaria the indoor air quality was evaluated in 92 
classrooms in winter 2004-2005 and in 75 classrooms in summer 2005. Indoor 
formaldehyde concentrations ranged from 3.1 to 46.1 µg/m3 (from 2.5 to 37.2 ppb) 
(Fromme et al, 2008). 
In Belgium, Hainaut Province Sanitary Surveillance Centre carried out measurements 
in 25 day-care centres (passive sampling during 48 hours) between March and June 
2008 (HVS, 2009). In one of them, formaldehyde concentration was above the 100 
µg/m3 (80.6 ppb) intervention value established by the Flemish Community; in 16 of 
them, the formaldehyde concentration was above the 10 µg/m3 (8.1 ppb) objective 
value fixed by the authorities. 
In nine Austrian schools, located both in urban and rural areas, a median of 30 µg/m3 
(24.2 ppb) and a maximum value of 136 µg/m3 (110 ppb) have been reported for 
indoor formaldehyde concentration when sampling (active) one week long (LUKI, 
2008).  
Within the frame of the AIRMEX project (Kotzias et al, 2009), formaldehyde 
concentrations were measured in European kindergartens located in 11 European 
cities (n=57; 7 days passive sampling) between 2004 and 2007. The average 
concentration of formaldehyde was 17.4 µg/m3 (14 ppb) and ranged from 1.5 µg/m3 
(1.2 ppb) to 49.7 µg/m3 (40 ppb). 
In the frame of BUMA project (Prioritization of Building Materials Emissions), 
monitoring surveys were conducted in two Mediterranean cities (Nicosia and Athens) 
in winter period, in four buildings in each city (one public building, one school and two 
houses) (Bartzis et al, 2009). Indoor formaldehyde concentrations ranged between 
5.8 – 43.2 µg/m3 (4.7 to 34.9 ppb). Additional results from this project are expected 
soon. 
 
In public premises one European study is mentioned. In Germany, active sampling of 
indoor air was conducted for 4 hours during the main visiting hours in 28 premises in 
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the cities of Augsburg and Munich, from April 2005 to May 2006 (Bolte et al, 2008). 
Median levels of formaldehyde were 17 µg/m3 (13.7 ppb) in restaurants and cafés 
(n=11), 17 µg/m3 (13.7 ppb) in pubs and bars (n=7), and 47.0 µg/m3 (37.9 ppb) in 
discotheques (n=10) (no smoke-free legislation). 
 
Table 3.1.1.1. Indoor exposures to formaldehyde and attribution to sources (ordered 
by countries; large-scale studies are cited first and mentioned in bold characters) 
 
STUDY 
AM/sAMA 
(µg/m³) 
GM/sGMB 
(µg/m³) 
Median 
(µg/m³) 
RangeC 
(µg/m³) 
Data 
collection 
year 
Type of 
buildings 
GerES 1 
      
Survey 1985/86 58.6 49.4/1.9  309 (max)  Homes 
Survey 1991/92 79   816 (max)  Homes 
Survey 2003/06 25.7 23.3 23.5 68.9 (max) 2003-2006 Homes 
(children’s 
bedroom) 
South Bavaria, 
Germany 22 
   3.1-46.1 Winter 04-
05 + 
summer 05 
Schools 
Germany 23   28 76 (p95) 2001-2004 Offices 
Augsburg and 
Munich,Germany 
24
 
14 (restaus) 
23 (pubs) 
47 (discos) 
 17 
(restaurants) 
17 (pubs) 
47 (discos) 
28 
(restaurants) 
63 (pubs) 
86 (discos) 
April 05-
May 2006 
Public 
premises 
 
      
EXPOLIS 2 
      
Helsinki   44.8 25.7 1.5-217.5 1996-1997  
OQAI 3               
France 
    19.6 (18.4-
21.0) 
86.3 (max) 2003-2005 Homes 
(bedrooms) 
Paris4   18.6/1.8 18,4 5% - 95%: 7.5 
– 45.5 
 Homes of 
new-born 
Strasbourg 25 32.2/14.6    Feb.-May 
04 + Oct. 
04-May 05 
Homes 
6-cities, France 26 27   4-100 1999 Schools 
Results 
 34 
STUDY 
AM/sAMA 
(µg/m³) 
GM/sGMB 
(µg/m³) 
Median 
(µg/m³) 
RangeC 
(µg/m³) 
Data 
collection 
year 
Type of 
buildings 
Strasbourg 27 27 (primary) 
22 
(element.) 
18 (day-
care) 
 24 (primary) 
20 (element.) 
 
85 (primary) 
80 (element.) 
122 (day-
care) 
Nov. 04-
Jan. 05 
Schools and 
day-care 
centres 
Rhône-Alpes 
Region, France 28 
24.1 
(schools) 
18.6 (day-
care) 
  8.6-49 
(schools) 
7.3-41 (day-
care) 
June 06-
March 07 
Schools and 
day-care 
centres 
Aarhus, Denmark5 37     - 290  Homes 
Umeå, Sweden6 9     3 - 18  Offices 
Borås, Sweden7 26/14   23 9.9 - 58  Homes 
(bedrooms) 
Göteborg, 
Sweden7 
35/22   29 8.6 - 120  Homes 
(bedrooms) 
Uppsala, Sweden8   3/3.5   - 72  Schools 
 
      
BRE (UK) 
  22,2 24 1-61.2-171  Homes 
 
      
ALSPAC 25/21   1-205  Homes 
(main 
bedroom) 
 23/17   1-181  Homes 
(living room) 
 
      
AIRMEX 
      
All cities      WorkplaceE 
      Homes 
Brussels 13.9/5.6     WorkplaceE 
 19.5/3.0     Homes 
Budapest 18.2/6.8     WorkplaceE 
 24.4/9.2     Homes 
Leipzig 22.9/10.4     WorkplaceE 
 18.6/13.4     Homes 
Helsinki 19.7/9.8     WorkplaceE 
 28.6/9.3     Homes 
Arnhem 17.7/10.4     WorkplaceE 
 30.7/17.8     Homes 
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STUDY 
AM/sAMA 
(µg/m³) 
GM/sGMB 
(µg/m³) 
Median 
(µg/m³) 
RangeC 
(µg/m³) 
Data 
collection 
year 
Type of 
buildings 
Athens 20.5/8.8     WorkplaceE 
 24.1/12.9     Homes 
Catania 14.7/5.0     WorkplaceE 
Dublin 17.5/13.3     WorkplaceE 
 14.4/4.9     Homes 
Nijmegen 19.5/6.8     WorkplaceE 
 30.1/24.2     Homes 
Thessaloniki 20.6/8.3     WorkplaceE 
Belgium       
Flanders 29 21 to 35     Homes 
All Belgium 30 18.1   4.1-103 March-
June 2008 
Day-care 
centres 
Austria 31   30 136 (max) 2006-2007 Schools 
Other countries       
Japan17    91.25 -290   
UK18  22.2 (19.5 -
26.1) 
    
Australia19   15.8 139 (max)   
Louisiana, USA20    <LOQD-6.6   
USA21    <LOQD-575   
AAM = arithmetic mean and average concentration, sAM = standard deviation of arithmetic mean 
B
 GM = geometric mean, sGM = standard deviation of geometric mean 
C
 Range = minimum and maximum value 
D
 LOQ = limit of quantification 
E "workplace" = working environments (offices, classrooms, waiting halls) in public buildings, schools 
and kindergartens 
 
1
 EXPOLIS 1999 and KUS, 2008; 2 Jurvelin et al. 2001; 3 Kircher et al. 2006; 4 Dassonville et al. 2009; 5 Harving 
et al. 1992; 6 Glas et al. 2004; 7 Gustafsson et al. 2005; 8 Smedje et al. 2001; 9 Raw et al. 2004; 10 Bruinen de 
Bruin et al. 2008; 11 INDEX 2005; 12 WHO 1989; 13 COMEAP 1997; 14 Jurvelin et al. 2001; 15 EPA/Cal 2003; 16 
THADE 2004; 17 Minami et al. 2002; 18 Brown et al. 2002a; 19 Garret et al. 1999; 20 Lemus et al. 1998; 21 Liu et al. 
1991; 22 Fromme et al, 2008; 23 BGIA, 2004; 24 Bolte et al, 2008; 25 Marchand et al, 2008; 26 Annesi-Maesano, 
2001; 27 ASPA, 2005; 28 Rhône-Alpes, 2007; 29 VITO, 2007; 30 HVS, 2009; 31 LUKI, 2008 
 
3.1.2 Hazard characterisation  
Two studies on humans have been considered particularly relevant to characterise 
the hazard from formaldehyde.  
Results 
 36 
One study was conducted on a group of 21 healthy volunteers exposed over a 2-
week period to different continuous levels of formaldehyde in controlled conditions, 
with and without occurrences of concentration peaks, using a repeated exposure 
design (Lang et al., 2008). Each subject was exposed for 4 hours to each of the 10 
exposure conditions on 10 consecutive working days. Eye irritation was found to be 
the most sensitive health outcome. Eye and nasal irritation were objectively observed 
at continuous exposure to 0.5 ppm with peaks of 1 ppm exposure, but not at constant 
exposure to 0.5 ppm. Effects reversed 16 hours after the end of the exposures. No 
significant effects on nasal flow and resistance, pulmonary function and reaction 
times were observed. It was concluded that a NOEL for subjective and objective eye 
irritation is 0.5 ppb in case of constant exposure levels, and 0.3 ppm with peaks of 
0.6 ppm in case of short-term peak exposure.  
Another study was conducted on asthmatic volunteers in controlled conditions to 
evaluate the influence of pre-exposure to low-dose formaldehyde (100 µg/m3, 0.08 
ppm, for 30 min) on bronchial response to a mite allergen (Casset et al. 2006). 
Subjects exposed to formaldehyde developed an immediate bronchial response at a 
significantly lower dose of mite allergen than after air exposure, suggesting that 
formaldehyde, in some way, might be involved in asthma exacerbation.  
 
Concerning toxicity in animals, two studies in particular addressed the time-effect 
relationships of formaldehyde concentrations on airways. 
In the first study (Nielsen et al. 1999), several irritation and respiratory parameters 
(such as air flow limitation or broncho-constriction patterns) in relation to 
formaldehyde exposure of the duration of 30 minutes were monitored in mice. A 
NOEL value of 0.3 ppm was established for sensory irritation from the `just 
detectable effect' (JDE) method described by authors. They deduced that at low 
concentrations adverse effects are due to trigeminal nerve stimulation.  
In a more recent study (Andersen et al, 2008) rats were exposed to formaldehyde 6 
hours per day, 5 days per week, up to 3 weeks. Endpoints considered included 
inflammatory infiltrate, epithelial hyperplasia and genomic signature in nasal epithelial 
tissues of rats. Inflammatory response was observed starting from 0.7 ppm (LOAEL), 
while a trend toward altered gene expression was observed between 0.7 and 2 ppm. 
As regards cell proliferation no effect was found below 2 ppm. 
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Documents published by international institutions are summarised and reviewed in 
Appendix D, Table A, while in Appendix D, Table B a summary of the most significant 
effects due to exposure to formaldehyde on humans and animals (excluding 
carcinogenicity) is reported. 
 
3.1.3 Exposure Reference Values 
The proposal for  reference exposure levels has been based on the three study 
chosen as pivotal (one on humans and two on animals), by applying safety factors 
chosen according to WHO/IPCS (IPCS, 2006) to the identified relevant endpoints. 
The choice of the Chemical Specific Assessment Factor (CSAF) has been based on 
several assumptions.; Humans have lower target tissue exposure to the substance 
than rodents that are nose-only breathers. Nevertheless, it may be that the effects of 
the substance on the nose of rodents have a predictive value for effects in humans 
on more distal parts of the respiratory tract, such as larynx, bronchi, and lungs 
(Casanova et al, 1991) thus, in the calculation of reference value a CSAF of 1 has 
been assigned to formaldehyde.  
 
Study No. 1   Nielsen et al., 1999 
Study population   Male BALB/cA mice (n=32; 4 per exposure group). 
Exposure Mice were inserted into body plethysmographs connected 
to the exposure chamber; exposure concentrations of 
formaldehyde were from 0.2 to 13 ppm. Duration of 
exposure was 30 minutes. 
 
Critical effects Sensory irritation parameters; air flow limitation or 
broncho-constriction patterns. 
 
Endpoint considered Sensory irritation  
NOEL    0.3 ppm.  
Uncertainty factor 3.16  
Comment Being mice nose-only breathers, humans are supposed to 
have lower target tissue exposure to the active chemical 
moiety for the same external dose. Thus, no uncertainty 
factor has been considered for interspecies variability. An 
uncertainty factor of 3.16 for intra-species toxicodynamic 
only has been applied, assuming that effects here 
considered are local and do not involve toxicokinetics. 
 
Reference value 0.095 ppm (≈120 µg/m3)  
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Study No. 2    Andersen et al., 2008 
Study population  Rats (n=8 per group, per time-point) 
Exposure Inhalation chamber, 6 h/day, 5d/week, up to 3 weeks. 
Exposure groups: 0.7, 2, 6 and 15 ppm. 
Critical effects Nasal mucosa: inflammatory infiltrate, epithelial 
hyperplasia, gene changes (squamous metaplasia, cell 
proliferation at higher concentrations) 
 
Endpoint considered Inflammatory infiltrate 
LOAEL 0.7 (measured 0.6) ppm  
Uncertainty factor 3 X 3.16 = 9.48 
Comment  Being mice nose-only breathers, humans are supposed to 
have lower target tissue exposure to the active chemical 
moiety for the same external dose. Thus, no uncertainty 
factor has been considered for interspecies variability. An 
uncertainty factor of 3.16 for intra-species toxicodynamics 
has been applied, assuming that effects here considered 
are local and do not involve toxicokinetics, multiplied for 
the adjustment factor of 3 for the use of a LOAEL.  
 
Reference value 0.074 ppm (≈90 µg/m3) 
 
 
Study No. 3    Lang et al., 2008 
Study population:  21 healthy volunteers (11 males, 10 females) 
Exposure Repeated measure design; each person exposed to both 
constant and peak levels for 4h and 10 consecutive days 
in 10 different exposure conditions. 
 
Critical effects Eye irritation (conjunctival redness, blinking frequency), 
nasal flow and resistance, pulmonary function and 
reaction times. 
 
Endpoint considered Eye irritation 
LOAEL   0.5 ppm with 1 ppm peaks 
NOAEL   0.5 ppm constant level (or 0.3 ppm with 0.6 ppm peaks) 
Uncertainty factor 3.16 
Comment An uncertainty factor of 3.16 for intra-species 
toxicodynamic only has been applied, assuming that 
effects here considered are local and do not involve 
toxicokinetics. 
 
Reference values 0.158 ppm (≈ 200 µg/m3) constant level 
 0.095 ppm (≈ 120 µg/m3) with peaks (0.190 ppm- ≈ 235 
µg/m3) 
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Based on objective eye irritation, the reference value proposed for short-term 
exposure to formaldehyde is in the range of 70-100 ppb (90-120 µg/m3).  
Results 
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3.2 Exposure characterisation and Exposure Scenarios in 
hospitals 
 
3.2.1 Uses and exposure determinants identified 
Based on the operational conditions observed during the first inspection at Pathology 
Unit of University Hospital L. Sacco and, taking into account exposure determinants, 
6 tasks have been identified as critical for formaldehyde exposure: 
1. Formalin dilution to operational concentration; 
2. Specimens dissection; 
3. Inclusion of specimens into containers (dissection room); 
4. Inclusion of specimens into containers (central lab); 
5. Disposal (pouring); 
6. Disposal (rinsing). 
 
Table 3.2.1.1 reports the critical tasks and exposure determinants identified at 
Pathology Unit of University Hospital L. Sacco are reported. Mitigation measures in 
place at the time of the survey are also reported. 
 
Table 3.2.1.1 Potentially critical tasks that entail use of formalin identified at 
University Hospital L. Sacco 
 
 
Task/Use 
 
Description Environment (room) 
Concentration & 
Quantity Frequency Duration 
Mitigation 
measures 
1. Formalin 
dilution 
Formalin is diluted 
into distilled water 
to operational 
condition. 
Dissection room 
(B). 
From 30 to 4% m/v 
formaldehyde 
solution; 
V: 10 L. 
Twice a 
week. 
Few 
minutes. 
Ventilated 
bench. 
2. Specimens 
dissection 
Specimens coming 
from other units, 
already put in 
formalin, are cut 
into thinner 
sections or 
sampled for 
suitable pieces. 
Dissection room 
(B). 
4% m/v 
formaldehyde 
solution;  
V: 10 times 
specimen volume. 
Daily. Several hours. 
Ventilated 
bench. 
3. Specimens 
inclusion (1) 
Specimens (high 
volume) are placed 
into containers and 
filled with formalin 
Dissection room 
(B). 
4% m/v 
formaldehyde 
solution;  
V: 10 times 
specimen volume 
(up to several L). 
Daily. 
NQ1 
(probably 
few 
minutes) 
Ventilated 
bench. 
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Task/Use 
 
Description Environment (room) 
Concentration & 
Quantity Frequency Duration 
Mitigation 
measures 
4. Specimens 
inclusion (2) 
Specimens 
(biopsies) are 
placed into bio-
cassettes and filled 
with formalin 
Central lab (A) 
4% m/v 
formaldehyde 
solution;  
V: 10 times 
specimen volume 
(<10 mL/container). 
Daily. ~30 
minutes. 
Chemical 
hood. 
5. Pouring  
Residual formalin 
present in 
containers is 
poured into 
apposite sink 
Dissection room 
(B). 
4% m/v 
formaldehyde 
solution;  
V: 10 times 
specimen volume 
(up to several L).. 
Daily Few 
minutes. 
Ventilated 
bench. 
6. Rinsing 
Recyclable 
containers are 
washed under tap 
water 
 
Washing room 
(Z) 
 
4% m/v 
formaldehyde 
solution  
V: NQ1 
Almost daily. Few 
minutes. 
None (no 
ventilation, no 
windows). 
 
1NQ: not quantifiable. 
 
 
The second hospital investigated, being a Cancer Institute, has a larger Pathology 
Department, divided into three sections (two dedicated to routine pathology and one 
to research). Direct uses of formalin, which are identified as critical, have been 
described and reported in table 3.2.1.2. 
 
Table 3.2.1.1 Potentially critical tasks that entail use of formalin identified at National 
Cancer Institute. 
 
Task/Use 
 
Description Environment (room) 
Concentration & 
Quantity Frequency Duration 
Mitigation 
measures 
1. Specimens 
dissection (1) 
Fresh1 organs 
coming from other 
units are cut into 
thinner sections. 
Dissection room 
(A) 
4% m/v 
formaldehyde 
solution;  
V= up to 20 L for 
big organs,  
Daily  Several hours 
Chemical hood 
(kept switched 
on for 1 our 
after operation 
has finished) 
2. Specimens 
dissection (2) 
Biopsies coming 
from other units, 
already put into 
formalin, are 
sampled for 
suitable pieces. 
Dissection room 
(A) 
4% m/v 
formaldehyde 
solution; V= 10 mL  
Daily  Several hours 
Chemical hood 
(kept switched 
on for 1 our 
after operation 
has finished) 
3. Specimens 
inclusion 
Formalin is poured 
into the containers 
through the 
opening of a tap. 
Dissection room 
(A) 
4% m/v 
formaldehyde 
solution;  
V= up to 20 L for 
big organs, 10 mL 
for biopsies; 
Daily Several 
minutes Chemical hood 
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4. Biopsy 
positioning 
Small dimension 
biopsies already 
included in 
formalin, are put 
into bio-cassettes.  
Processing room 
(B) 
4% m/v 
formaldehyde 
solution;  
V= 10 mL. 
Daily ~ 1 hour Chemical hood 
5. Formalin 
upload and 
download  
Formalin is 
uploaded and 
downloaded from 
processing 
machine. 
Processing room 
(B) 
4% m/v 
formaldehyde 
solution; 
V= 5 tanks of 5 L, 
total: 10 L. 
1-2 times 
per day 
~15 
minutes 
Exhaust 
ventilation: 20 
air exchange 
per hour 
(theoretical).  
6. Bio-
cassettes 
upload and 
download 
Bio-cassettes are 
positioned inside 
formalin in the 
processing 
machine. 
Processing room 
(B) 
4% m/v 
formaldehyde 
solution; 
V: 10 L. 
2 upload & 
download 
per day for 
each 
machine 
(total: 8 
times/day) 
Few 
minutes 
Exhaust 
ventilation: 20 
air exchange 
per hour 
(theoretical). 
7. Pouring  
Residual formalin 
present in 
containers is 
poured into 
apposite sink. 
Dissection room 
(A) 
4% m/v 
formaldehyde 
solution;  
V= 10 mL. 
Daily  
Few 
seconds 
per 
container 
Chemical hood 
8. Disposal of 
archive 
specimens  
Residual formalin 
present in big, 
containers of 
archive is poured 
into apposite sink. 
Disposal room 
(C) 
4% m/v 
formaldehyde 
solution;  
V = up to 20 L. 
Almost daily Up to 1 hour. Chemical hood 
9. Rinsing 
Recyclable 
containers are 
washed under tap 
water 
 
Disposal room 
(C) 
4% m/v 
formaldehyde 
solution  
V: NQ2 
Almost daily Few 
minutes Chemical hood 
10. Washing 
Recyclable 
containers are put 
inside washing 
machine 
 
Ex-autopsy room 
(D) 
4% m/v 
formaldehyde 
solution  
V: NQ2 
Almost daily Few 
minutes  None 
 
1 Fresh: not included in formalin 
2NQ : not quantifiable  
 
Due to working organisation and timing it has not been possible to carry out any 
sampling for some of the tasks. Sometimes two or more tasks have been monitored 
at the same time. Further, some other situations or tasks identified as potentially non-
critical have been monitored as described in paragraph 3.2.3. 
 
3.2.2 Preliminary measurements 
A screening monitoring at University Hospital L. Sacco has been conducted with 
passive method Dräger Bio-check-F during the first visit at Pathology Unit. 2 hours 
TWA of formaldehyde air concentrations have been measured in three environments: 
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1. Central lab (Room A): during various tasks which do not involve direct use of 
formalin such inclusion into paraffin, colouration, sorting and labelling. Less 
than usual activity has been reported. 
2. Dissection room (room B): during organ dissection. 
3. Archive, located in the basement (room C), where numerous specimens are 
archived in containers. 
Another sampler has been pinned on an operator during her routine activity, which 
has been performed in central lab mostly. Reportedly less than usual work has been 
carried out that day. 
Outcomes of the preliminary monitoring survey are reported in table 3.2.2.1. 
 
Table 3.2.2.1 Outcomes of the preliminary monitoring at University Hospital L. Sacco. 
 
Sample Room Time Class Concentration 
range Observations 
1 Archive at the basement (C) 11.37 – 13.37 C 0.1 - 0.2 ppm No activity. 
2a Central lab (A) 11.46 – 13.46 B 0.05 - 0.1 ppm Various “indirect” tasks 
2b Central lab (A) 12.53 – 14.53 B 0.05 - 0.1 ppm Various “indirect” tasks 
3 On operator in 
central lab (A) 11.43 – 13.43 B 0.05 - 0.1 ppm 
Various “indirect” 
tasks 
4a Dissection 
room (B) 11.48 – 13.48 E ≥ 0.3 ppm Cutting of a big organ 
4b Dissection 
room (B) 12.52 – 14.52 E ≥ 0.3 ppm No activity 
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3.2.3 Monitoring survey at University Hospital L. Sacco 
 
The monitoring has been conducted in July 2010, during routine activity of the 
Pathology Unit. Tasks monitored with 3 techniques have been: 
1. Specimens dissection and inclusion into formalin in dissection room (including 
cutting of large organs); 
2. Various tasks not involving the direct use of formalin such as specimens 
processing, inclusion into paraffin, colouration, microtome sectioning and 
specimens sorting in central lab; 
3. Formalin dilution in dissection room; 
4. Specimens inclusion in central lab (small biopsies); 
5. Pouring of residual formalin in dissection room (5 high volume containers up to 
5 L). 
 
Other environments have been monitored with passive sampler Bio-check F and/or 
photo-acoustic gas monitor. On personnel request, one Bio-check F measurement 
has been performed in the cellar where archives are stored (situation no. 6). A task 
identified as critical, rinsing of recyclable containers, could not be performed because 
no used containers were present that day, nevertheless a measurement with photo-
acoustic and Bio-check has been carried out while rinsed containers were drying 
(situation no. 7). Both environments (cellar and washing room) are not provided with 
any ventilation system. 
Data and charts depicting relevant outcomes are presented in this section. Relevant 
occurrences observed during measurements are reported in charts. 
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During situation no. 1 (specimens dissection and inclusion into formalin) 
formaldehyde concentrations detected have been: 
 
- Photo-acoustic: maximum 1.48 ppm; mean 0.5 ppm (n=67); 
- CMS: maximum 0.27; mean 0.26 ppm (n=11); 
- Bio-check F: class D (0.2-0.3 ppm). 
 
The peak of concentration detected occurred during cutting of a large organ, and no 
particular occurrence has been observed. 
 
Chart 3.2.3.1 Specimens dissection and inclusion into formalin in dissection room 
(Pathology Unit, University Hospital L. Sacco) 
 
 
 
0,00
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0,40
0,60
0,80
1,00
1,20
1,40
1,60
10.25 10.42 10.59 11.17 11.34 11.51 12.08 time
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m
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dissection no activity 
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on desk 
pouring 
formalin 
 dissection  
(big organs) 
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During situation no.2 (various “indirect” tasks in central lab) concentrations detected 
have been: 
- Photo-acoustic: maximum 1.05 ppm; mean 0.32 ppm (n=42); 
- CMS: maximum 0.26 ppm; mean 0.24 ppm (n=3);  
- Bio-check F: class B (0.05-0.1 ppm). 
 
As depicted in chart 3.2.3.2, a peak of concentration is to be noted. It has been 
detected after the arrival of new specimens already included in formalin left on a desk 
(not under chemical hood). At the same time, the door left open between central lab 
and dissection room has been observed. 
 
Chart 3.2.3.2 Various tasks in central lab (Pathology Unit, University Hospital L. 
Sacco) 
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During situation no. 3 (formalin dilution in dissection room) concentrations detected 
have been: 
- Photo-acoustic: maximum 0.69 ppm; mean 0.53 ppm (n=6); 
- CMS: maximum 0.32 ppm, mean 0.24 ppm (n=2); 1 measurement has been 
below LOD (0.2 ppm); it started before the operation beginning and ended 
during task. 
- Bio-check F: class E (≥0.3 ppm). 
 
Chart 3.2.3.3 Formalin dilution in dissection room (Pathology Unit, University Hospital 
L. Sacco) 
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During situation no. 4 (biopsies inclusion into formalin in central lab) concentrations 
detected have been: 
- Photo-acoustic: maximum 1.35 ppm; mean 0.49 ppm (n=18); 
- CMS: maximum 0.23 ppm, mean 0.22 ppm (n=3);  
- Bio-check F: class D (0.2-0.3 ppm). 
 
To be noted, as depicted in chart 3.2.3.4, the peak concentration detected just after 
the chemical hood has been switched off. 
 
 
Chart 3.2.3.4 Biopsies inclusion into formalin in central lab (Pathology Unit, University 
Hospital L. Sacco) 
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During situation no. 5 (disposal: pouring residual formalin in dissection room) 
concentrations detected have been: 
- Photo-acoustic: maximum 0.61 ppm; mean 0.53 ppm (n=7); 
- CMS: maximum 0.42 ppm, mean 0.38 ppm (n=2);  
- Bio-check F: class E (≥0.3 ppm). 
 
Chart 3.2.3.5 Formalin disposal in dissection room (Pathology Unit, University 
Hospital L. Sacco) 
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Results of other environments monitored are reported in table 3.2.3.1 
 
Table 3.2.3.1 Other environments monitored at Pathology Unit, University Hospital L. 
Sacco 
Formaldehyde levels 
Situation Environment 
Bio-check F Photo-
acoustic 
Notes 
6. Specimen 
archives 
Basement (room C) Class E (≥ 0.3ppm) - 
Organs kept in 
non-hermetic bins 
7. Washing 
 
Washing room 
(room Z) 
Class B 
(0.05 - 0.1ppm) 
Below detection 
limit (0.04 ppm) 
No activity; 
containers left to 
dry. 
 
Results 
 50 
The maximum concentration detected has been 1.48 ppm (photo-acoustic monitor) 
during specimens dissection and inclusion into formalin in dissection room (room B). 
Peak concentrations above 1 ppm have been detected by the photo-acoustic monitor 
in three situations (no.1, no.2, no.4, dissection, biopsies inclusion and during various, 
“indirect”, operations respectively). 
Summary data of the air monitoring at University Hospital L. Sacco are reported in 
table 3.2.3.2 
 
Table 3.2.3.2 Summary data of University Hospital L. Sacco monitoring 
 
Photo-acoustic 
(ppm) 
CMS 
(ppm) 
Bio-check F 
(ppm) Task/situation  Environment 
Max Average Max Average 2 hrs TWA 
No. 1 Room B 1.48 0.5 0.27 0.26 ≥ 0.3 
No. 2 Room A 1.05 0.32 0.27 0.24 0.05-0.1 
No. 3 Room B 0.69 0.53 0.32 0.24 ≥ 0.3 
No. 4 Room A 1.35 0.49 0.23 0.22 0.2-0.3 
No. 5 Room B 0.61 0.53 0.42 0.38 ≥ 0.3 
No. 6 Room C - - - - ≥ 0.3 
No. 7 Room Z < LOD - - - 0.05-0.1 
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3.2.4 Monitoring survey at National Cancer Institute 
The monitoring has been conducted at the end of October 2010, during routine 
activity of the Pathology Unit. Situations monitored with at least two techniques have 
been: 
1.  Specimens dissection (2): sampling of biopsies and inclusion into formalin (tap 
of formalin tank opened several times) in dissection room; 
2. Formalin upload and download in processing room; 
3. Specimens dissection (1): cutting of “fresh” organs (not already included into 
formalin) and inclusion into formalin in dissection room; 
4. Disposal of archive specimens (pouring residual formalin) in disposal room; 
5.  Washing of recyclable containers in ex autopsy room (CMS and Bio-check F 
only); 
6. Biopsies positioning in processing room; 
7. Bio-cassettes upload and download in processing room (photo-acoustic and 
CMS); 
8. Pouring of residual and loading of new formalin in dissection room (photo-
acoustic and CMS). 
 
Data and charts depicting relevant outcomes are presented in this section. Relevant 
occurrences observed during measurements are reported in charts. 
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During situation no. 1 (biopsies sampling and inclusion into formalin) formaldehyde 
concentrations detected have been: 
- Photo-acoustic: maximum 0.35 ppm; mean 0.07 ppm (n=27); 
- CMS: below LOD (0.2 ppm; n=5) 
- Bio-check F: class E (≥ 0.3 ppm). 
 
Chart 3.2.4.1 Biopsies sampling and inclusion into formalin (Pathology dept. National 
Cancer Institute) 
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1. Observation  no. 1: operator passed above instruments with gloves soaked with formalin 
2. Observation no. 2: formalin tank opened for 1 min ca. 
           1    2 
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In situation no. 2, formalin upload and download in processing room, photo-acoustic 
measurements have been invalidated because of positive interferences present in 
the room (ethanol and xylenes), thus cannot be used to depict formaldehyde levels. 
Concentrations detected with other two methods have been: 
- CMS: maximum 0.54 ppm, mean 0.35 ppm (n=2);  
- Bio-check F in processing room: null measurement; 
- Bio-check F positioned in the corridor, in front of the door between processing 
room (left open): class D (0.2- 0.3 ppm). 
 
Chart 3.2.4.2 Formalin upload and download in processing room (Pathology dept. 
National Cancer Institute) 
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1. Observation no. 1: download started. 
2. Observation no. 2: automatic upload started (1st tank). 
3. Observation no. 3: manual upload started (2nd tank). 
4. Observation no. 4: accidental pouring on the floor. 
 
           1     2       4   3
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During situation no. 3, cutting of organs, not already included into formalin 
(specimens dissection 1) and inclusion into formalin in dissection room formaldehyde 
concentration detected have been: 
- Photo-acoustic: maximum 0.25 ppm; mean 0.12 ppm (n=30); 
- CMS: maximum 0.3 ppm; mean 0.24 (n=5); 2 measurements below LOD (0.2 
ppm); 
- Bio-check F: class E (≥ 0.3 ppm). 
 
As Bio-check F sampler has been applied on an operator (operator no.1) which has 
carried out assistance to the pathologist which performed these tasks. The operator 
has also opened the formalin tank many times. Due to the different purpose of 
measurement (personal vs environmental sampling) concentration detected is not 
comparable to those of photo-acoustic and CMS sampler, thus it has not been 
reported in the same chart. 
 
Chart 3.2.4.3 Organs cutting and inclusion into formalin in dissection room (Pathology 
dept. National Cancer Institute) 
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1. Observation no. 1: High volume containers of formalin (5 L ca.) left open under chemical hood 
 
1 
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During situation no. 4, disposal of archive specimens (pouring residual formalin) in 
disposal room formaldehyde concentration detected have been: 
- Photo-acoustic: maximum 2.25 ppm; mean 1.24 ppm (n=25); 
- CMS: maximum 2.25 ppm; mean 0.60 (n=7);  
- Bio-check F: class E (≥ 0.3 ppm). 
 
Chart 3.2.4.4 Archives disposal: pouring of residual formalin in disposal room 
(Pathology dept. National Cancer Institute) 
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1. Observation no. 1: accidental pouring on the floor. 
2. Observation no. 2: strong, suffocating odour, monitoring work team left the room. 
 
During situation no. 5, washing of recyclable containers in ex autopsy room 
formaldehyde concentration have been detected with CMS and Bio-check F only: 
- CMS: maximum 0.26 ppm; mean 0.25 (n=2);  
- Bio-check F: class D (0.2-0.3 ppm). 
Due to few, short-time, data collected, related chart has not been reported since it 
does not add any supportive information. 
 
           1            2 
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During situation no. 6, biopsies positioning in bio-cassettes in processing room, 
photo-acoustic measurements have been invalidated because of positive 
interferences present in the room (ethanol and xylenes), as well as in situation no.2. 
Concentrations detected with other two methods have been: 
- CMS: maximum 0.29 ppm; mean 0.25 (n=4);  
- Bio-check F: class E (≥ 0.3 ppm). 
In this case also, due to few, short-time, data collected, related chart has not been 
reported since it does not add any supportive information. 
 
Situation no. 7, bio-cassettes upload and download in processing room, has been 
characterised by the presence of positive interferences too (for photo-acoustic). Bio-
check F sampler has not been considered worthy to use because of the brevity of the 
task. Thus, only data from CMS are reported: 
- CMS (1 measurement): 0.3 ppm 
Chart is not reported. 
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During situation no. 8, pouring of residual and loading of new formalin in dissection 
room, concentration of formaldehyde have been detected with photo-acoustic monitor 
and CMS sampler only. Bio-check F sampler has not been considered worthy to use 
because of the brevity of the task. Outcomes have been: 
- Photo-acoustic: maximum 0.6 ppm; mean 0.34 ppm (n=5). 
- CMS: maximum 0.24 ppm; mean 0.24 ppm (n=2) 
 
Chart 3.2.4.5 Pouring residual and loading new formalin in dissection room 
(Pathology dept. National Cancer Institute) 
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Other environments, i.e. rooms where there is not a direct use of formalin, have been 
monitored with passive sampler Bio-check F. Personal monitoring have been also 
carried out with Bio-check F sampler on four operators involved in different tasks. All 
Bio-check F measurements reported levels in class E (≥0.3 ppm) as reported in table 
3.2.4.1 
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Table 3.2.4.1 Various situations and environments monitored with Bio-check F at 
National Cancer Institute. 
Sample Environment Time 
Tasks carried 
out during 
monitoring 
Class 
Formaldehyde 
concentrations 
(ppm) 
1 
Dissection room 
(space 1) 10.10-12.10 
Biopsies sampling, 
opening of formalin 
tank. E  ≥0.3 
2 
Dissection room 
(space 2) 10.10-12.11 
Various; no biopsies 
sampling C  0.1-0.2 
3 
Corridor A (next 
to dissection 
room) 10.18-12.18 Passageway A ≤0.05 
4 Cytology lab 10.18-12.18 Various/not specified B 0.05-0.1 
5 
Secretary office 
A (small room) 10.22-12.22 Secretary activities A ≤0.05 
6 
Experimental 
Molecular 
Pathology lab 10.24-12.24 Various/not specified A ≤0.05 
7 
Diagnostic 
Molecular 
Pathology lab 10.24-12.24 Various/not specified B 0.05-0.1 
8 
Processing 
room  11.05-13.05 
Formalin upload and 
download from 
processing machines Null  - 
9 
Corridor B (in 
front of 
processing 
room) 11.15-13.15 
Passageway; door 
open between 
corridor and 
processing room 
during 
upload/download D 0.2-0.3 
10 
Paraffin and 
colouration lab  11.20-13.20 Various/not specified B 0.05-0.1 
11 Histology lab 11.32-13.32 Personnel meeting B 0.05-0.1 
12 
Operator 1: 
dissection room 12.40-14.40 
Assistance to 
sampling and cutting; 
formalin tank opening. E  ≥0.3 
13 
Operator 2: 
processing 
room 13.00-15.00 
Formalin upload and 
download from 
processing machines E  ≥0.3 
14 
Ex autopsy 
room 13.10-15.10 
Loading of containers 
into washing 
machines; washing 
cycle; drying of 
containers D 0.2-0.3 
15 Disposal room 13.10-15.10 
Pouring of residual 
formalin  (ca. 15 big 
containers 2-3 L and 
20 small 250 mL) E  ≥0.3 
16 
Secretary office 
B (large room) 13.25-15.25 Secretary activities B 0.05-0.1 
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Sample Environment Time 
Tasks carried 
out during 
monitoring 
Class 
Formaldehyde 
concentrations 
(ppm) 
17 
Processing 
room 13.35-15.35 
Positioning of small 
biopsies in bio-
cassettes E  ≥0.3 
18 
Immune-histo-
chemistry lab 13.35-15.35 Various/not specified B 
0.05-0.1 (media 
0.075) 
19 
Corridor B (in 
front of 
processing 
room) 13.37-15.37 
Positioning of small 
biopsies in bio-
cassettes in 
processing room 
(door open) Null - 
20 
Operator 3: 
disposal room, 
ex autopsy 
room; 13.52-15.52 
Archives disposal 
(pouring formalin), 
loading washing 
machines E  ≥0.3 
21 
Operator 4: 
processing 
room 
14.55-
rimozione 
Positioning of small 
biopsies in bio-
cassettes Null  - 
 
The maximum concentration detected in monitoring survey has been 2.25 ppm 
(found with both photo-acoustic and CMS methods) during pouring of residual 
formalin in disposal room (room C), the only task/situation to produce peak 
concentrations above 1 ppm. In three situations (no. 2, 6, 7) photo-acoustic 
measurements gave very high peak concentrations, but have been discarded 
because of the presence of positive interferences inside processing room. Summary 
data of the air monitoring at National Cancer Institute are reported in table 3.2.4.2. 
 
Table 3.2.4.2 Summary data of National Cancer Institute monitoring 
Photo-acoustic 
(ppm) 
CMS 
(ppm) 
Bio-check F 
(ppm) Task/circumstance 
monitored 
Environment 
Max Average Max Average 2 hrs TWA 
No. 1 Room A 0.35 0.07 < LOD - ≥ 0.3 
No. 2 Room B Dis1 Dis1 0.54 0.35 0.2-0.3 
No. 3 Room A 0.12 0.25 0.3 0.24 ≥ 0.3 
(operator) 
No. 4 Room C 2.25 1.24 2.25 0.65 ≥ 0.3 
No. 5 Room D - - 0.26 0.25 0.2-0.3 
No. 6 Room B Dis1 Dis1 0.29 0.25 ≥ 0.3 
No. 7 Room B Dis1 Dis1 0.3 0.3 - 
No. 8 Room A 0.6 0.34 0.24 0.24 - 
1Dis: discarded because of positive interferences. 
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3.2.5 Exposure Scenarios and Risk Management Measures proposal 
Exposure Scenario development has been based on REACH Regulation Guidelines, 
particularly on the document “Guidance on information requirements and chemical 
safety assessment - Part D: Exposure Scenario Building” (ECHA, 2008). First, a 
checklist has been completed during the personnel interviews and the inspection of 
laboratories. To answer some questions, the support of the Prevention and 
Protection Service of both hospitals has been required.  
Always basing the Scenario development on REACH Technical Guidance, an 
exposure estimation model has been taken into account and, as exercise, tested on 
a generic task repeated several times per day in a pathology laboratory (see 
Appendix A). The concentration estimated are in the same order of magnitude of 
those encountered during the surveys and the detailed results of exposure modelling; 
the model description and the input/output data are reported in Appendix A. 
Exposure data obtained from air monitoring surveys have been evaluated and 
implemented into the Exposure Scenario. Concentration values exceeding TLV-C for 
formaldehyde (0.3 ppm) have been highlighted, trying to describe possible causes of 
exceeding formaldehyde levels. Further, Risk Management Measures (RMMs) for 
each task resulting in a potential risk for operators health have been proposed. 
Exposure Scenarios developed are presented in a re-arranged format based on 
REACH guidelines. An Exposure Scenario can pool more than one task together. 
This is the case when two or more task are carried out at the same time and in the 
same environment, where the single source of emission is not distinguishable during 
a routine work activity (i.e specimens dissection and inclusion into formalin). Also 
various, indirect, tasks performed in the same environment where a relevant, single 
source of formaldehyde is not expected, have been grouped in the same Exposure 
Scenario. 
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University Hospital L. Sacco 
Among tasks and situations monitored (7), five of them presented formaldehyde 
levels clearly exceeding the TLV-C, (situations no 1, 2, 3, 4 and 5). Thus, five 
Exposure Scenarios have been developed and presented to the Prevention and 
Protection Service of the Hospital.  
 
Exposure Scenario no. 1 
Scenario name Specimens dissection and inclusion into formalin 
Task description 
Specimens coming from other units, already put in formalin, are cut 
into thinner sections or sampled for suitable pieces which are placed 
into containers and filled with formalin. 
1 
 
Exposure determinants 
Environment Dissection room (room B) 
Concentration 4% m/v formaldehyde solution 
Quantity 10 times specimen volume (up to several L) 
Duration Several hours 
Frequency Daily 
Existing mitigation 
measures 
Ventilated bench 
1 
 
Operator exposure 
Photo-acoustic  CMS Bio-check F 
Formaldehyde air levels 
Peak: 1.48 ppm; 
Average: 0.5 ppm; Max: 0.27 ppm class D (0.2-0.3 ppm) 
TLV exceeded YES NO NO 
Causes identified for 
exceeding concentrations 
- Poor exhaust ventilation (no chemical hood). 
- Very small room size (2 operators can hardly work). 
1 
 
Proposed Risk Management Measures 
1. Re-arrange rooms and working spaces: functional to tasks. 
2. Provide effective exhaust chemical hood. 
3. Use of personal protective equipment during most critical situation (i.e. mask with AX filter). 
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Exposure Scenario no. 2 
Scenario name Various tasks (indirect) 
Task description 
Several routine operations, which do not involve the direct use of 
formalin such as processing, inclusion into paraffin, colouration, 
microtome sectioning and specimens sorting. 
1 
 
Exposure determinants 
Environment Central lab(room A) 
Concentration 4% m/v formaldehyde solution 
Quantity NQ1 
Duration Task dependent  
Frequency Daily 
Existing mitigation 
measures 
Chemical hoods (6) 
1 
 
Operator exposure 
Photo-acoustic  CMS Bio-check F 
Formaldehyde air levels 
Peak: 1.05 ppm; 
Average: 0.32 ppm; Max: 0.27 ppm class B (0.05-0.1 ppm) 
TLV exceeded YES NO NO 
Causes identified for 
exceeding concentrations 
- Specimens included in formalin, and probably not sealed, left on a 
bench (no hood).  
- Door left open between room A and B (dissection room). 
1 
 
Proposed Risk Management Measures 
1. Provide general safety indication to all personnel of the Unit (i.e. close doors, do not leave 
formalin containers outside hoods, ventilated benches or cupboards). 
2. Avoid misuses, providing task-specific training to personnel involved (i.e. moving specimens) 
1NQ: not quantifiable. 
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Exposure Scenario no. 3 
Scenario name Formalin dilution 
Task description Formalin, provided in tanks from Pharmacy Unit, is diluted to operational condition into distilled water. 
1 
 
Exposure determinants 
Environment Dissection room (room B) 
Concentration From 30 to 4% m/v formaldehyde solution 
Quantity 10 L 
Duration Few minutes (<5) 
Frequency Twice a week 
Existing mitigation 
measures 
Ventilated bench 
1 
 
Operator exposure 
Photo-acoustic  CMS Bio-check F 
Formaldehyde air levels 
Peak: 0.69 ppm; 
Average: 0.53 ppm; Max: 0.32 ppm class E (≥ 0.3ppm) 
TLV exceeded YES YES YES 
Causes identified for 
exceeding concentrations 
- Poor exhaust ventilation (no chemical hood). 
- Very small room size (2 operators can hardly work). 
- Emission of formaldehyde during dilution is unavoidable. 
1 
 
Proposed Risk Management Measures 
1. Provide the Unit with formalin already diluted to operational condition (buying directly from 
supplier). 
2. Re-arrange rooms and working spaces: functional to tasks. 
3. Provide effective exhaust chemical hood. 
4. Use of personal protective equipment during most critical situation (i.e. mask with AX filter). 
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Exposure Scenario no. 4 
Scenario name Biopsies inclusion into formalin 
Task description Biopsies are placed into bio-cassettes and filled with formalin 
1 
 
Exposure determinants 
Environment Central lab (room A) 
Concentration 4% m/v formaldehyde solution 
Quantity <10 mL/container 
Duration ~30 minutes 
Frequency Daily 
Existing mitigation 
measures 
Chemical hood 
1 
 
Operator exposure 
Photo-acoustic  CMS Bio-check F 
Formaldehyde air levels 
Peak: 1.35 ppm 
Average: 0.49 ppm Max: 0.23 ppm class D (0.2-0.3 ppm) 
TLV exceeded YES NO NO 
Causes identified for 
exceeding concentrations - Exhaust hood is switched off too soon, just after the task is finished. 
1 
 
Proposed Risk Management Measures 
1. Avoid misuses, providing task-specific training to personnel involved (i.e. leave the hood 
switched on for a while after the work has been done). 
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Exposure Scenario no. 5 
Scenario name Disposal 
Task description Residual formalin present in containers is poured into apposite sink 
1 
 
Exposure determinants 
Environment Dissection room (room B) 
Concentration 4% m/v formaldehyde solution 
Quantity Up to several L (over 10 L very rare) 
Duration 10-15 minutes 
Frequency Daily 
Existing mitigation 
measures 
Ventilated bench 
1 
 
Operator exposure 
Photo-acoustic  CMS Bio-check F 
Formaldehyde air levels 
Peak: 0.61 ppm 
Average: 0.53 ppm Max: 0.42 ppm class E (≥ 0.3ppm) 
TLV exceeded YES YES YES 
Causes identified for 
exceeding concentrations 
- Poor exhaust ventilation (no chemical hood). 
- Very small room size (2 operators can hardly work). 
- Containers are poured too fast. 
1 
 
Proposed Risk Management Measures 
1. Re-arrange rooms and working spaces: functional to tasks. 
2. Provide effective exhaust chemical hood. 
3. Avoid misuses, providing task-specific training to personnel involved (i.e. wait few minutes 
between pourings) 
4. Use of personal protective equipment during most critical situation (i.e. mask with AX filter). 
 
An Exposure Scenario for situation no. 6 at University Hospital Luigi Sacco has not 
been developed. The situation has not been monitored with CMS sampler and photo-
acoustic monitor because the task (archiving) was not supposed to be critical, 
however on personnel request a Bio-check-F sampler has been activated. 
Formaldehyde concentrations increased if compared to results of preliminary 
campaign (class E vs class C), and this is probably due to the presence of unsealed 
containers of biological material put in a normal bin. Although archive is located in the 
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cellar, and operators do not stay there for a long nor they go down frequently, the 
removal of unsealed containers from bins is recommended, as well as the sealing of 
material to be kept as archive into cupboards (already present). 
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National Cancer Institute 
Among tasks monitored (8), three of them presented formaldehyde levels clearly 
exceeding the TLV-C (no 2, 4 and 8). Tasks no 4 and 8 consist in the same 
operation, however are carried out in different environment. Further, the disposal of 
formalin in specimens kept in archive (in disposal room) concerns a relevant number 
of containers poured at same time, while the task conducted in dissection room is 
usually a routine task and involves fewer containers per time. Thus, three Exposure 
Scenarios have been developed. 
 
Exposure Scenario no. 1 
Scenario name Formalin upload and download 
Task description 
Formalin is uploaded, and downloaded, from processing 
machines. To facilitate, a funnel positioned on the tank is 
used during download. This operation can be performed 
both manually and automatically. 
1 
 
Exposure determinants 
Environment Processing room (room B) 
Concentration 4% m/v formaldehyde solution 
Quantity 20 L (2 tanks of 5 L for both upload and download) 
Duration Less than 15 min 
Frequency Daily (sometimes twice a day). 
Existing mitigation measures Exhaust ventilation system: 20 air exchange per hour (theoretical). 
1 
 
Operator exposure 
Photo-acoustic  CMS Bio-check F 
Formaldehyde air levels 
- 
Max: 0.54 ppm 
(average 0.35 ppm) 
class D (0.2-0.3 
ppm)* 
TLV exceeded - YES NO 
Causes identified for 
exceeding concentrations -Spills of formalin on the floor (usual occurrence) 
1 
 
Proposed Risk Management Measures 
1. Avoid misuses, providing task-specific training to personnel involved (i.e. pay attention 
to potential spills during upload and download). 
2. Use of personal protective equipment during most critical situation (i.e. mask with AX 
filter). 
*Bio-check F sampler located in the corridor in front of room B 
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Exposure Scenario no. 2 
Scenario name Archives disposal 
Task description Residual formalin present in containers of archive is poured into apposite sink. 
1 
 
Exposure determinants 
Environment Disposal room (room C) 
Concentration 4% m/v formaldehyde solution 
Quantity NQ1 
Duration Up to 1 hour. 
Frequency Few times per week. 
Existing mitigation 
measures 
Chemical hood. 
1 
 
Operator exposure 
Photo-acoustic  CMS Bio-check F 
Formaldehyde air levels 
Peak: 2.25 ppm 
Average: 1.24 ppm Max: 2.25 ppm  
class E (≥0.3 
ppm) 
TLV exceeded YES YES YES 
Causes identified for 
exceeding 
concentrations 
-A large number of containers is emptied at the same time, in 
a very fast way. 
-Spills of formalin on the floor (usual occurrence) 
1 
 
Proposed Risk Management Measures 
1. Avoid misuses, providing task-specific training to personnel involved (i.e. wait few 
minutes between pourings, pay attention to potential spills) 
2. Use of personal protective equipment during most critical situation (i.e. mask with AX 
filter). 
1NQ: not quantifiable. 
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Exposure Scenario no. 3 
Scenario name Formalin pouring  
Task description Residual formalin present in containers is poured into apposite sink. Containers are re-filled with new formalin 
1 
 
Exposure determinants 
Environment Dissection room (A) 
Concentration 4% m/v formaldehyde solution 
Quantity Up to 5 L. 
Duration Few seconds per container 
Frequency Daily 
Existing mitigation 
measures 
Chemical hood. 
1 
 
Operator exposure 
Photo-acoustic  CMS Bio-check F 
Formaldehyde air levels 
Peak: 0.6 ppm 
Average: 0.34 ppm Max: 0.24 ppm  - 
TLV exceeded YES NO - 
Causes identified for 
exceeding 
concentrations 
-Containers are poured too fast 
1 
 
Proposed Risk Management Measures 
1. Avoid misuses, providing task-specific training to personnel involved (i.e. wait few 
minutes between pourings) 
2. Use of personal protective equipment during most critical situation (i.e. mask with AX 
filter). 
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Pictures taken during monitoring at University Hospital L. Sacco: 
1: Dissection of organs in dissection room (to be noted ventilated bench)  
 
 
2. Archives kept in the basement 
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Pictures taken during monitoring at National Cancer Institute: 
1. Sampling and inclusion into formalin under chemical hood in dissection room  
 
2.Formalin download (a) and upload (b) (manual) in processing room 
 
 
 72 
Discussion 
 
 
4.1 European Project INDEX-UPRIC 2009 
 
4.1.1 Levels of exposure among EU population 
In the most recent surveys, the average levels of formaldehyde indoor ranged 
between 15 and 50 µg/m3 (12 and 40 ppb). The maximum values were significantly 
lower than in the 1980s, as can be noted when comparing the various surveys 
carried out in Germany (GerES studies) to the most recent ones from France (OQAI, 
Indoor Air Quality Observatory) and AIRMEX project. The trend of decreasing 
concentrations can be partially attributed to the less emitting materials being 
developed over time in the context of various labelling schemes put in place in 
different European countries. Very high concentrations, in particular, have become 
less common. However, formaldehyde still features as one of the most common 
indoor air pollutants. In particular, data collected suggest that concentrations inside 
home are higher than those measured in offices and schools. Wood based materials, 
and furniture, due to their formaldehyde-resins content, are one of the main sources 
of formaldehyde, especially at the beginning of their employment. New buildings, 
dwellings furnished with many wood based materials, low ventilation, high 
temperatures and humidity (which facilitate the hydrolysis of formaldehyde molecules 
from resin’s terminals), typically experience higher formaldehyde levels when 
compared to buildings with opposite characteristics.  
Although formaldehyde is considered from scientific community a likely human 
carcinogen, and a major indoor air pollutant that has been acknowledged and 
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measured for decades across Europe, detailed and representative data on general 
population exposure indoors in European Union are still scarce.  
 
In order to better understand and comment INDEX UPRIC 2009 outcomes, a brief 
summary of the first edition is reported. 
 
4.1.2 INDEX 2005 summary 
The first edition of EU project INDEX “Critical Appraisal of the Setting and 
Implementation of Indoor Exposure Limits in the EU” has been funded by DG 
SANCO in 2004. The project objectives were the risk assessment for several 
pollutants representative of indoor air settings, the proposal of reference values of 
exposure and, recommendation of risk management measures (Kotzias et al, 2005). 
Substances “of concern” identified as priority (Group 1) for indoors were: 
formaldehyde, nitrogen dioxide, carbon monoxide, benzene, naphthalene. 
Formaldehyde, due to its adverse effects and its ubiquity, was deemed as the most 
problematic. Other chemicals were considered to be “second priority chemicals” 
(Group 2): acetaldehyde, toluene, xylenes, styrene. In Group 3: have been included 
“chemicals requiring further research with regard to human exposure or dose 
response”: ammonia, limonene, α-pinene. 
Concerning formaldehyde, a risk characterisation for general population was carried 
out. A NOAEL of 0.03 mg/m3 (24 ppb) was derived based on the lowest 
concentration estimated not to give effects in the normal population. This evaluation, 
expressed  by Californian OEHHA, was based on a Scandinavian work survey 
(Wilhelmsson and Holmstrom 1992), in which 66 workers of a chemical plant 
complained nasal and eye irritation, nasal obstruction, and lower airway discomfort. 
In the context of a risk characterisation experiment, the NOAEL was further divided 
by an assessment factor of 30, taking into account intra-species variation (10) and 
the consideration that children may be more sensitive than adults to formaldehyde 
respiratory toxicity (3). This experiment resulted in a paradoxical exposure limit of 1 
µg/m3 (0.8 ppb), which is the background concentration of formaldehyde in rural 
areas. Nevertheless, the exposure limit officially proposed in INDEX 2005 for 
formaldehyde was equivalent to the NOAEL, 30 µg/m3 (24 ppb). Looking at exposure 
surveys, it emerged that almost the entire EU population was exposed at indoors 
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levels (median level ± sd: 26 ± 6 µg/m3; 90th ± sd: 59 ± 7 µg/m3; N = 6) higher than 
the background, with at least 20% of the European population exposed at levels 
exceeding 30 µg/m3.  
 
4.1.3 Reconsideration of formaldehyde exposure limits 
After the proposal concerning formaldehyde exposure limits made by INDEX 2005 
some criticism arose (Arts et al. 2008). Arts et al. from Netherlands Organisation for 
Applied Scientific Research (TNO) published in 2008 a review funded by the 
FormaCare sector group of the European Chemical Industry Council (CEFIC), 
assessing the risk characterisation carried out in the INDEX 2005 project. In this 
paper the indoor air level of 1 µg/m3 (0.8 ppb) used in the risk characterisation 
exercise has been evaluated. The threshold for sensory irritation in human volunteers 
was identified to be 1 ppm (1,24 mg/m3), higher than the 100 µg/m3 (~80 ppb) 
indicated by WHO and considered in the INDEX 2005 project. The authors 
considered that nose and throat irritation, at concentrations below which 
hyperplasia/metaplasia occurs, are most likely the consequence of trigeminal nerve 
stimulation (sensory irritation). Eye irritation is recognised as the most sensitive effect 
reported in human volunteers, but it is considered as a merely local reaction that 
requires, if any, a low assessment factor. Concerning children vulnerability in relation 
to asthma, it is stressed the difficulty to judge the sensitivity in children because of 
the potential confounding factors in the evaluated studies. It is concluded that an 
indoor air level of 120 µg/m3 (~0.1 ppm) can be considered safe and appropriate for 
the general population, as indicated by Appel et al. in 2006. 
The INDEX UPRIC 2009 project, adopted a different, up-to-date approach in 
assessing formaldehyde hazards for human health and in indoor exposure limit 
calculation, basing its assumptions on the most recent scientific data, choosing 
objective, clear, toxicological endpoints from studies conducted in controlled 
conditions of exposure and applying chemical specific uncertainty factors as 
described in chapter Materials and Methods. 
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4.1.4 Protection from effects other than irritation 
Several considerations have been elaborated to explain and support the reference 
value calculated.  
The range of concentration proposed in INDEX UPRIC 2009 (70-100 ppb or 90-120 
µg/m3), is considered protective also from impairment of pulmonary function. Human 
studies investigating asthma and hyper-sensitisation due to formaldehyde exposure 
are not entirely consistent among each other and there is no clear and unambiguous 
evidence that children may be more sensitive to formaldehyde toxicity than adults. 
However, a possible mechanism explaining the association of the formaldehyde 
exposure with asthma exacerbation has been recently hypothesised (OEHHA, 2008). 
There is also some concern about synergistic effects between formaldehyde and 
allergens that may favourite asthma exacerbation (Casset et al., 2006). 
The threshold for pulmonary effects is above 1 ppm, as most studies investigating 
this endpoint report a LOAEL between 2 and 3 ppm (Paustenbach et al. 1997). A 
potential uncertainty factor for children and asthmatic subjects vulnerability should be 
applied to these threshold values, and not to NOELs for sensory irritation. In the 
hypothesis of applying a default uncertainty factor of 10 to the threshold for 
pulmonary effects, the reference value obtained would be in the order of 0.1 ppm, 
which is in the same range of the one based on sensory irritation.  
Toxicological data from long-term studies seem to show that irritating effects are 
concentration rather than dose (i.e, concentration per time) depended. Paustenbach 
1997, OEHHA 2008 and others reviewed several chronic and sub-chronic studies on 
animals (Rush et al 1983, Wilmer et al 1989, Woutersen et al 1989), which suggest 
the concentration-dependent nature of irritation and cytotoxicity due to formaldehyde 
exposure. Particularly, OEHHA deems that NOAELs and LOAELs are similar in the 
reviewed studies regardless of exposure duration, and did not apply any ‘sub-chronic 
uncertainty factor’ in the calculation of chronic Reference Exposure Limits (RELs). 
Also pulmonary functionality was reported to be not affected in sub-chronic exposure 
to formaldehyde concentrations below 2 ppm.  
Nevertheless, further toxicological data related to exposure to long-term, low 
average, levels of formaldehyde, are required to exclude any life-long cumulative 
effect. 
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Concerning carcinogenicity, the most accredited hypothesis is that inhalation of 
formaldehyde under conditions that induce cytotoxicity and sustained regenerative 
proliferation within the respiratory tract does represent a carcinogenic hazard (Liteplo 
and Meek, 2003). The carcinogenic process may be explained as the result of 
cytotoxic damage following severe tissue irritation (Arts, Rennen and de Heer 2006). 
Therefore, preventing irritation should be sufficient in order to protect from the 
potential carcinogenic effect in upper airways, which is generally observed in animals 
starting from long-term exposure to 6 ppm (Kerns et al 1983, Monticello et al. 1996). 
However, outcomes of in vivo genotoxicity studies (currently inconclusive) will have to 
be considered, particularly in relation to a potential association of formaldehyde with 
other tumours than those located in the site of exposure (airways tissues), such as 
lympho-hematopoietic tumours. 
 
Since the reference concentration range here calculated, 70-100 ppb or 90-120 
µg/m3 for short term exposure is, at least, one order of magnitude lower than the 
threshold level observed for cytotoxic damage in the nasal mucosa (Arts, et al. 2006, 
WHO 2000), the general population exposed to these concentrations can be 
considered to be protected also against the risk for nasal-pharyngeal cancer. 
Outcomes from studies about genotoxic effects are currently not entirely consistent, 
but should be evaluated and taken into account in the assessment of formaldehyde 
carcinogenic potential, considering also other tumours sites than nasopharyngeal 
cancers, such as lymphohematopoietic system. In addition, biologically-motivated 
computational modelling can be a useful tool in evaluating cancer risk for human 
respiratory tract (Conolly et al 2003 and 2004). Relevant outcomes on this topic 
published so far have been reported in table B of Appendix D.  
 
4.1.5 Comparison with other reference values 
Although selected studies for endpoint identification and the method of calculation 
are different, the exposure reference range proposed by INDEX UPRIC 2009 is in the 
same order of magnitude of several short-term exposure limits for indoor environment 
recommended by several organisation. These guideline values, which have been 
published in last years, i.e. by HEALTH CANADA (2005), AFSSET - France (2007), 
RIVM – The Netherlands (2007) and by OEHHA - US (2008), are reported in table 
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4.1.3.1. Further, in Appendix D most of the formaldehyde evaluations by international 
or national institutions are reported and discussed. 
 
Table 4.1.3.1. Proposed formaldehyde air quality guidelines (indoor/outdoor) by 
several national/international organisations 
 
FORMALDEHYDE AIR QUALITY GUIDELINES 
(µg/m3) 
 
Short-term 
exposure 
8-hour 
average 
Long-term 
exposure 
WHO (2000): Air quality 
guidelines.  
100 (1) 
(30-minute average)  
- - 
HEALTH CANADA (2005): 
Proposed residential 
indoor air quality 
guidelines for 
formaldehyde.  
123 (2) 
(1-hour average) 
 
50 (2) - 
AFSSET (2007):  French 
indoor air quality 
guidelines. 
50 (3) 
(2-hour average) 
- 10 
RIVM (2007): Health-
based guideline values for 
indoor environment 
120  
(30-minute average)  
- 1.2(4) 
10 –annual 
average(5) 
 
OEHHA (2008) 
 
55 9 9 
(1) “Exposure level at which there is a negligible risk of upper respiratory tract cancer in humans”. 
(2) “The cancer risk associated with a lifelong exposure to that concentration of formaldehyde is 
estimated to be negligible”. 
(3) “Also protecting against other suspected effects, such as respiratory function impairment”. 
(4) Adopted by RIVM in 1995  
(5) MPR Adopted by VROM (Ministry of Housing, Spatial Planning and the Environment) 
 
 
4.1.6 The relevance of exposure characterisation 
As shown in recent surveys, formaldehyde remains one of the most common indoor 
air pollutant. Particular attention must be paid to the exposure assessment which is a 
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requisite for risk assessment and management purposes. The association of possible 
health effects encountered in exposed population with environmental levels 
especially, should be analysed with awareness, looking at concentration fluctuations 
and at the monitoring method adopted. Among available exposure data reported in 
indoor air surveys, results are often not adequate to perform a risk characterisation. 
Reasons can be identified in several aspects, being probably the most important the 
fact that, very often, concentrations are reported as TWA of several hours or even 
days; neither average concentrations are representative of real levels of exposure 
nor a specific health endpoint can be correctly associated to TWA. Further, in many 
surveys exposure determinants are not identified and/or exposure scenarios are not 
thoroughly understood. 
However, in some studies reported here, concentrations above 100 µg/m3 have been 
observed and can be expected to occur quite often during some domestic tasks or 
soon after home refurbishment, especially in the absence of proper ventilation. Other 
common practices resulting in secondary sources of formaldehyde indoors, may even 
worsen the scenario of short-term/acute exposure to formaldehyde. For example, the 
more and more widespread use of fragrances or air fresheners can result, in 
presence of ozone (even at very low concentrations), in formaldehyde and ultra-fine 
particulate matters production (ECA-IAQ, 2007). Environmental Tobacco Smoke too 
is considered a relevant source of formaldehyde in domestic setting as well as the 
use of antibacterial detergents. 
The matter is that such situations that are potentially leading to peak concentrations 
can hardly be detected with conventional, in particular passive, air monitoring 
techniques and without a deep understanding of exposure scenarios. 
In the light of above considerations, health effects reported in community surveys 
should not be associated with time-weighted average levels, which are usually 
reported when using traditional air monitoring techniques (either active or passive). If 
possible, eventual adverse effect shall be related to concentrations exceeding a 
certain threshold. Most of the air monitoring campaigns carried out until now are not 
detailed enough to fully characterise the exposure and, hence, to perform a correct 
risk evaluation. The identification of crucial situations leading to formaldehyde 
exposure as well as of all the parameters determining its emission, spatial distribution 
and air concentration can improve the scenario depiction. Moreover, the adoption of 
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in-continuous gas detectors, capable to identify and monitor emissions in real-time 
i.e. during critical circumstances, can easily detect exceeding air levels.  
 
4.1.7 Recommendations 
 
The exposure reference value for formaldehyde is suggested to be 70-100 ppm or 
90-120 µg/m3 as short-term exposure (30 minutes). In order to reduce and contain 
formaldehyde exposure the following actions are recommended to policy makers:  
• Minimise the emissions of formaldehyde from building materials, products and 
furnishings (i.e. through the application of certification systems); 
• Discourage the use of formaldehyde in household/office products; 
• Require product labelling providing information on potential formaldehyde 
release from household and building products; 
• Ensure health based ventilation for indoor environments; 
• Raise public awareness and provide information to the public about the 
sources and prevention of risks from exposure to formaldehyde in indoor 
environments. 
 
Long-term implications 
Toxicological data associated with long-term exposure to formaldehyde are currently 
not exhaustive to define a long-term exposure level to exclude life-long health 
hazards. In any case, in order to meet the short-term reference range proposed, 
long-term average exposure levels (i.e. those detected with passive air monitoring) 
will need to be kept significantly lower, in order to take into account exposure 
fluctuations and short–term releases of formaldehyde. 
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4.2 Exposure characterisation and Exposure Scenarios in 
hospitals 
 
4.2.1 Occupational exposure to formaldehyde in Pathology laboratories. 
Occupational exposure to formaldehyde presents marked differences if compared 
with indoor exposure, especially for what concern laboratory settings. Personnel 
working in Pathology units (technicians, anatomists, pathologists, researchers, 
students and attendants) are exposed, even if to very different extents, to 
concentrations generated by their working activity, during various tasks which involve 
the use (or the presence) of formalin. Formaldehyde contained in the solution easily 
evaporates and produces peaks of concentration in the close vicinity. Those peaks 
can even reach ppm levels posing a non-negligible risk for personnel health.  
In table 4.2.1.1 some studies published in the last 10 years investigating occupational 
exposure to formaldehyde in Pathology labs are reported. Using either passive or 
active sampling techniques , both environmental and personal monitorings show that 
formaldehyde levels can reach worrying concentration (see in particular Orsiere et al, 
2006, and Costa et al, 2008). 
 
Table 4.2.1.1 Levels of formaldehyde exposure in Pathology laboratories reported 
during the last decade.  
Study 
Sampling method 
reported 
Exposure level 
Personal sampling 8 
hrs TWA 
 
0.04÷1.6 ppm 
 
Costa et al, 2008 
Environmental 
sampling 8 hrs TWA 
-macroscopic examination: 1.50 ppm; 
-disposal: 4.4 ppm. 
Pala et al, 2008 Personal passive 
sampling 8 hrs TWA 
(among different 
hospital units, including 
pathology). 
3.5÷216.1 ppb 
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Study 
Sampling method 
reported 
Exposure level 
Active sampling 15 min <0.1÷20.4 ppm. Orsiere et al, 2006 
Passive sampling 8 hrs 
TWA 
 
<0.1÷0.7 ppm 
Environmental 
sampling (4-6 hrs) 
0.23÷1.03 ppm. 
 
Ohmichi et al, 
2006 
 
Personal sampling 
(1.1-6 hrs) 
0.80, 0.45 and 0.51 ppm (instructors)  
1.02, 1.08 and 0.89 ppm (students). 
Burgaz et al, 2002 Active monitoring in the 
breathing zone 
(sampling time not 
reported) 
2÷4 ppm 
0.04÷0.7 ppm (laboratory assistants and 
technicians). 
 
Shaham et al, 
2002 
Personal and 
environmental 
sampling (15 min). 
0.72÷5.6 ppm (physicians and hospital 
orderlies). 
 
 
Air sampling methods reported in literature are often not described in detail. Being 
detected with an in-continuous (photo-acoustic gas monitor) or with an active, short-
time, technique (maximum 10 minutes measurement, CMS sampler), maximum 
levels of formaldehyde measured in our study seem, to be generally lower than many 
of those reported in table 4.2.1.1 
 
4.2.2 Comparison of exposure data with the TLV-C  
 
Threshold Limit Values (TLVs) are set by American Conference of Industrial 
Hygienists (ACGIH) to be protective of both acute and long term adverse effects on 
workers professionally exposed to a certain substance. The comparison of the TLV to 
concentration values measured with the three techniques in both hospitals is 
necessary to identify situations leading to potentially critical exposure for operators’ 
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health. For formaldehyde the TLV is set at 0.3 ppm as ceiling value (TLV-C) 
indicating that this exposure limit should not be exceeded at any time. In 
consideration of this, values to be compared with the threshold limit should be 
measured within the shortest time period to be representative of real levels exposure. 
In fact, in the case of exposure to formaldehyde in occupational settings, the 
sampling time is a crucial issue, as due to the nature of the substance, fluctuations of 
air concentration might occur suddenly. Photo-acoustic monitor, giving a 
measurement every ~90 seconds appears to be the most suitable method for the 
purpose. Hence, a primary importance is given to photo-acoustic monitor results in 
representing actual levels of exposure in respect to those of the other two monitoring 
techniques.  
As reported in chapter Results, CMS and Bio-check F samplers present 
discrepancies when compared to photo-acoustic, but also between each other, 
principally due to different sampling times. Both CMS and Bio-check-F samplers 
cannot give a real-time reading of air concentrations, thus concentration values 
measured in 5-10 minutes or 2 hours respectively, have to be compared with caution 
to a threshold limit. 
In this study, to consider the exposure during a task as critical and therefore, to 
implement an Exposure Scenario, it has been sufficient that results of photo-acoustic 
monitor clearly exceeded the TLV-C even if the other two did not. In the case of 
invalidated photo-acoustic measurements, CMS and Bio-check F samplers have 
been carefully evaluated and used for the comparison with the TLV-C. 
 
University Hospital L. Sacco  
Among formaldehyde levels found at University Hospital L. Sacco, 76% of the photo-
acoustic  measurements (n=140) exceeded the TLV-C. In particular, 98%, 31%, 78% 
of the concentrations determined by the photo-acoustic monitor were higher than the 
TLV-C during dissection in room B (situation no. 1), various tasks in room A (situation 
no. 2), and during biopsies inclusion into formalin in room A (situation no. 4), 
respectively. Further, in these three situations formaldehyde levels exceeded 1 ppm 
for several minutes, indicating a characteristic “peak pattern” of exposure. Although 
all tasks grouped in situation no.2, were not identified as critical, as they do not 
involve the direct use of formalin, levels of formaldehyde measured reached a peak 
of 1.05 ppm. Such a concentration is not attributable to routine tasks carried out 
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during the measurement (i.e. specimens processing, colouration, microtome, sorting) 
and sources have to be searched somewhere else. During formalin dilution and 
disposal in room B (situation no. 3 and 5) maximum level detected with photo-
acoustic method are somewhat lower, being 0.69 ppm and 0.61, respectively. 
However, 100% of photo-acoustic  measures are above the TLV-C in both situations.  
 
Concentrations measured by CMS sampler, although did not recognise peak levels, 
exceeded the TLV-C during situations 3 and 5 (maximum levels 0.32 and 0.42 ppm, 
respectively). This may reflect less fluctuating concentration patterns if compared 
with no. 1, 2 and 4, where data measured by CMS sampler resulted to be below the 
threshold limit. Also Bio-check F sampler reached the highest concentration class 
(≥0.3 ppm) in situation no. 3 and 5 (being 2 hours the measurement time, in the same 
environment, it has been used one sampler) but not in situations no. 2 and 4. 
Surprisingly, CMS sampler detected levels lower than the TLV-C during situation no. 
1 but did not Bio-check F (see summary in table 4.2.2.1). Bio-check F sampler 
reached the highest concentration class in situation no. 6 also, in room C (archive), 
also not expected to be critical when specimens are kept in sealed containers (the 
result of the preliminary monitoring was 0.1-0.2 ppm).  
 
Table 4.2.2.1 Summary data of University Hospital L. Sacco: concentrations 
exceeding ACGIH TLV-C for formaldehyde 
Task/situation Environment Photo-acoustic  % > TLV 
CMS 
 > TLV 
Bio-check F 
class 
≥ TLV 
No. 1 Room B 98 No Yes 
No. 2 Room A 31 No No 
No. 3 Room B 100 Yes (1/1) Yes 
No. 4 Room A 78 No No 
No. 5 Room B 100 Yes (2/2) Yes 
No. 6 Room C - - Yes 
No. 7 Room Z 0 (<LOD) - No 
 
National Cancer Institute 
Among formaldehyde levels found at National Cancer Institute, 32% of valid photo-
acoustic measurements (n=98) exceeded the TLV-C. A marked peak of 
concentration is found during disposal (pouring residual formalin, situation no. 4) 
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carried out in room C, where formaldehyde levels reached 2.25 ppm. The peak has 
the TLV-C) and CMS sampler. This may mean that concentrations above 2 ppm 
occurred for at least 5 minutes (minimum sampling time of CMS sampler). In the 
same situation, Bio-check F sampler resulted in class E in both environmental and 
personal monitoring.  
In situation no. 2, 6 and 7, photo-acoustic monitor results had to be discarded, as 
they have been invalidated due to the presence in the same environment (processing 
room) of ethanol and xylenes, which give positive interferences, while CMS sampler 
exceeded the TLV-C in situation no. 2 only (during formalin download and upload). 
Bio-check F sampler resulted equal or higher than the threshold limit in situation no. 6 
only (biopsies positioning in bio-cassettes). During formalin download and upload 
Bio-check F sample no. 8 had a void result. Thus, it has been considered Bio-check 
F sample no. 9 located in corridor B, just in front of the processing room (door left 
open, distance from operation < 2 m), as a surrogate for situation no. 2: it resulted in 
class D (0.2-0.3 ppm). 
During specimen dissection 1 (biopsies) and 2 (organs) (situations no. 1 and 3) 
photo-acoustic monitor results exceeded the TLV-C just once (concentration 
measured: 0.35 ppm) during biopsies sampling (see table 4.2.2.2.). However it has 
not been considered relevant enough to identify the task as critical and to develop an 
Exposure Scenario. CMS measurements seem to be in good accordance with photo-
acoustic monitor results in these situations, being the maximum levels detected not 
higher than the TLV-C. On the opposite, Bio-check F resulted in class E (≥ 0.3 ppm) 
in both situations, being aware that during situation no. 3 it has been pinned on the 
breast pocket of a technician (personal monitoring). 
Due to the strict schedule of the personnel involved, situation n. 5 (washing of 
recyclable containers in ex autopsy room) and 8 (pouring residual formalin in 
dissection room) have been monitored with 2 techniques only, CMS and Bio-check F 
samplers in the first case and, photo-acoustic monitor and CMS sampler in the 
second. Results were below the TLV-C with the exception of those obtained with 
photo-acoustic method during formalin pouring, whose measurements exceeded the 
TLV-C once (20%, 1 of 5 measurements). Even if conducted under chemical hood 
this task may lead to high level of exposure, thus it has been considered as critical, 
and an apposite Exposure Scenario has been developed (see the disposal of 
residual formalin from archive specimens, situation no. 4) 
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Personal monitoring conducted with Bio-check F samplers revealed a non-negligible 
condition of exposure of technicians, since the 3 valid samples resulted in the highest 
concentration class (equal or above the TLV-C). Working procedures adopted by 
operators during these and other situations have been observed during monitoring 
and are discussed in paragraph 4.2.3. 
All the other Bio-check F samplers used for screening purposes in many 
environments (see table 3.2.4.1 in chapter Results), have been useful to check levels 
of formaldehyde where fluctuations are not expected, as i.e. in offices, corridors or 
single laboratories where there is not a direct use of formalin. Only sample no. 9, 
located in corridor B in front of processing room during formalin download/upload 
(door left open), resulted in class D (0.2-0.3 ppm), while in all other environments 
concentration class detected is much lower (A or B). 
 
Table 4.2.2.2 Summary data of National Cancer Institute: concentrations exceeding 
ACGIH TLV-C for formaldehyde 
Task/situation Environment Photo-acoustic   
% > TLV 
CMS 
 > TLV 
Bio-check F 
class 
≥ TLV 
No. 1 Room A 4 No (<LOD) Yes 
No. 2 Room B Dis1 Yes (6/7) No 
No. 3 Room A 0 No Yes (operator) 
No. 4 Room C 100 Yes (3/7) Yes 
No. 5 Room D - No No 
No. 6 Room B Dis1 No Yes 
No. 7 Room B Dis1 No No 
No. 8 Room A 20 No - 
1Dis: discarded because of positive interferences. 
 
Sometimes, Bio-check F sampler measured not expected, “paradoxical”, 
formaldehyde concentrations if compared to photo-acoustic and CMS measurements 
in the same situation (namely, Bio-check F results higher than the other two, as in 
situation no 1 at National Cancer Institute). This may be explained by the fact that its 
sampling time has a fixed duration of 2 hours, in which it must be left in the same 
room. The other two techniques for organisation and schedule of the monitoring 
survey, are generally left to monitor the same task for one hour at maximum. After 
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that photo-acoustic monitor and CMS sampler have been removed, working 
conditions may have varied or an unnoticed circumstance have occurred.  
 
4.2.3 Considerations on proposed RMMs 
The two hospitals, being focused on different medical specialities, do present very 
different work organisation, logistic and mitigation measures already put into place. 
However, both present critical situations, potentially leading to a risk for operators’ 
health. A number of these situations can be resolved (at least partially) by paying 
attention on working procedures, especially avoiding misuses. To do this, personal 
training is a requisite. They must not only be informed on how to correctly perform a 
certain task, avoiding risky situations, but they must be aware of the intrinsic 
characteristics of formaldehyde such as physical-chemical behaviour (i.e. being a 
gas, it naturally tends to leave the solution) and toxicological properties. 
 
To summarise, Risk Management Measures proposed in the two hospital concern 
interventions to be implemented at different levels: 
 logistics: re-arranging room and spaces in function to tasks; 
 organisation: buying ready-to-use formalin, already diluted to operational 
dilution, as well as ready-to-use containers (already filled with formalin); 
 mitigation: providing effective ventilation (chemical hood or exhaust ventilation) 
 personal protective equipment: providing masks (i.e. AX filters) and also 
goggles  
 training: general indications to all staff of Pathology Units and specific to 
operator for critical tasks. Motivating personnel to use personal protective 
equipment is necessary. 
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4.2.4 Considerations on monitoring techniques 
Air sampling methods adopted in this study have been evaluated on the basis of the 
output data and their accordance (see also PCA analysis outcomes in Appendix C). 
Advantages and disadvantages arose for each technique can be summarised as 
follows. 
 
Bio-check F disposable sampler (passive technique) 
Advantages:  
 
 Easy to use; 
 Cheap; 
 Can be used for both environmental 
and personal sampling (pinned on any 
garment); 
 No maintenance needed; 
 Suitable for preliminary surveys or 
quick, undemanding controls;  
 Useful in environments not interested 
by the direct use of formalin (i.e. 
corridors, archives, offices), where 
relevant fluctuations in formaldehyde 
levels are not expected. 
 
Disadvantages: 
 
− Cannot recognise any fluctuations (giving 
a 2 hours TWA); 
− Not precise measuring (semi-quantitative 
reading); 
− Colour reading can be subjective; 
− Limited range of measurement for 
occupational purposed (max. ≥ 0.3 ppm). 
 
 
 
 
CMS sampler (active technique) 
Advantages:  
 
 Easy to use and move; 
 Quite cheap (if ordering many chips); 
 Quick reading on monitor; 
 Can be used for both environmental 
and personal sampling (strap 
provided); 
 No particular maintenance needed; 
 Can be used with different chips to 
monitor numerous other gases; 
 Measurement range suitable for 
occupational purposes (0.2-5 ppm) 
Disadvantages: 
 
− Difficulties in blank reading (due to chip 
calibration); 
− Manual activation; 
− Not effective to detect peak 
concentrations (tend to underestimate); 
− Reproducibility is not high: reported on 
label ± 30% ; this is confirmed on field; 
− Feels temperature and humidity effects 
(appears less reliable during summer 
season) 
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Photo-acoustic  gas monitor (in-continuous technique) 
Advantages:  
 
 Once switched on it gives 
approximately real-time measuring 
(one measure every~90 s) 
 Quick reading on monitor; 
 Effective to detect peak 
concentrations and fluctuations; 
 Measurement of other gases at the 
same time with apposite filters (i.e. 
methanol, CO2, etc..); 
 Measurement range suitable for 
occupational purposes (0.04 -10 ppm). 
Disadvantages: 
 
− Specificity: other gases can easily give 
interferences if specific filters are not 
assembled; 
− Expensive; 
− Need maintenance; 
− Cannot be used for personal sampling. 
 
 
 
 
 
In the light of above considerations, it seems that photo-acoustic gas monitor would 
be the most suitable and fit-to-purpose method to thoroughly understand 
formaldehyde air levels in occupational settings where high concentration fluctuations 
occur, such as Pathology laboratories. Nevertheless, many aspects have to be taken 
into account, starting from economic resources, but also the purposes of the survey. 
Of course, when characterising exposure in order to perform a risk assessment, or 
when associating formaldehyde levels with specific health effects encountered in 
exposed operators, an in-continuous technique is recommended. However, if a 
photo-acoustic gas monitor is chosen, particular attention must be paid to the aspect 
of interferences. Unfortunately, while sensitivity is very high (LOD is 0.04 ppm), 
specificity can be low if filters for those gases likely to interfere are not assembled on 
the device. In particular, when monitoring formaldehyde, possible (positively) 
interfering substances consist in alcohols and other low-weight aldehydes. A filter for 
methanol is assembled on the device used in this study and, when activated, it 
measures its air concentration at the same time of formaldehyde. This is very useful, 
since when measuring formaldehyde released from formalin buffered with methanol, 
as in the case of University Hospital L. Sacco, it can work as a control. If 
formaldehyde fluctuation has the same trend of methanol (see chart 4.2.4.1), it can 
be reasonably assumed that concentrations measured are due to the release from 
formalin, thus are not compromised by the presence of interferences. While 
monitoring at National Cancer Institute, instead, the possible presence of alcohols 
such as ethanol and xylenes in processing room has been promptly reported by 
operators. Photo-acoustic  measures resulted clearly affected by positive interference 
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attributable to these gases, having formaldehyde concentration shown on the monitor 
raised up to the unrealistic level of 18 ppm. Further, as in this hospital, formalin 
solution used is buffered with phosphates rather than methanol, no control method 
can be applied. This is the reason why all the measurements conducted with photo-
acoustic monitor in processing room have been discarded.  
 
Chart 4.2.4.1 Formaldehyde vs methanol fluctuations during specimens dissection at 
University Hospital L. Sacco. 
0.00
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In conclusion, a careful evaluation of the situation to be monitored is a requisite, as 
well as a consideration of the survey objectives, in order to adopt the most suitable 
method without wasting resources. For preliminary screenings, and undemanding 
checks, both passive (especially for those area where peaks are not expected) and 
active techniques such as Bio-check F and CMS samplers can be reasonable 
solutions, bearing in mind their most critical intrinsic limit, the missing depiction of 
peak concentrations.  
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Conclusions 
 
 
5.1 European Project INDEX-UPRIC 2009 
 
In 2009, DG SANCO funded an update of the 2005 project INDEX “Critical Appraisal of the 
Setting and Implementation of Indoor Exposure Limits in the EU”. DG SANCO required a 
particular focus on formaldehyde, on the basis of new papers published following its re-
classification in Group 1 (sufficient epidemiological and scientific evidence for an 
association with nasopharyngeal cancer) by IARC. INDEX-UPRIC 2009 (“UPdate of 
PRIority Compounds”) aimed at reviewing recent scientific data, but also at re-examining 
previous studies and re-considering the reference values proposed in 2005. From selected 
results of scientific literature and an innovative approach in applying uncertainty factors, 
making the best use of chemical specific data on toxicodynamics and toxicokinetics, new 
reference limits have been proposed for exposure to formaldehyde in indoor settings. 
The reference range of values for short-term exposure (30 minutes) proposed at EU level 
is 70-100 ppb (or 90-120 µg/m3); it is comparable to most of exposure limits set by other 
national or international organisation. WHO in particular, in the latest version of IAQ 
guidelines (just published in December 2010), even if resulting from a different calculation, 
recommends a limit of 100 µg/m3 (~80 ppb) for short-term exposure.  
The reference values proposed by INDEX UPRIC 2009 should be used for the risk 
characterisation of situations related to acute exposure to formaldehyde indoors. In the 
light of scientific data available, it can be considered protective from carcinogenic effects in 
relation to short-term exposure, although it is derived from an irritation endpoint. Always 
looking at the scientific evidence available so far, there is no indication of cumulative 
effects following exposure to low concentrations (below 1 ppm), as adverse effects seem 
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to recover shortly after exposure period. Current knowledge allows to reasonably assume 
that the proposed reference range of concentrations is also protective from long-term 
health effects due to repetitive short-term exposures. However, attention must be paid at 
the outcomes of genotoxicity studies (currently inconclusive), particularly with concern to a 
potential association of formaldehyde with increased incidence of tumours other than 
those located in the site of exposure (airways tissues). 
 
5.2 Exposure characterisation and Exposure Scenarios in 
hospitals 
 
The hazard characterisation of formaldehyde carried out in INDEX UPRIC project indicates 
that recurrent, short-term, peak exposures, rather than exposure to constant levels, are 
expected to adversely affect eyes and upper airways in exposed subjects, posing also a 
potential risk for more severe health outcomes. Exposure to formaldehyde in occupational 
settings, and particularly in Pathology labs, appears to be characterised by concentration 
fluctuations and peaks. To perform a correct exposure assessment in Pathology Units, and 
to eventually associate exposure levels with health effects, an in-depth understanding of 
determinant factors of exposure and actual air levels, is a requirement. The project aimed 
to reach this goal through the development of detailed Exposure Scenarios and the 
characterisation of concentration fluctuations during specific tasks in Pathology Units of 
two different hospitals.  
Three monitoring methods have been adopted: passive, active and in-continuous 
techniques have been tested and their outcomes analysed. Potential hazards for 
operators’ health have been identified during the performance of several tasks, being 
measured formaldehyde levels clearly above the TLV-C set by US ACGIH (0.3 ppm). From 
circumstances observed during monitoring, some misuses have been identified as well as 
inappropriateness of some organisational, logistic, and mitigation factors leading to high 
level of exposure (even above 1 ppm). Exposure Scenarios for critical tasks have been 
presented, including operational conditions, formaldehyde levels detected by the three 
techniques, possible causes of rises above the TLV-C, and proposed RMMs . 
Due to intrinsic properties of formaldehyde, its release from formalin solution is 
unavoidable, thus the implementation of RMMs is particularly crucial to avoid excessive 
exposure of operators. Much can be done in order to reduce critical situations, but 
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measures to put into practice must be shared within all personnel working in the Unit. Less 
problematic alternatives (i.e. glutaraldehyde) should be also taken into account, 
considering the current debate on carcinogenicity and being formaldehyde in revision of 
classification at EU level as a consequence of a French request to place it among 
Carcinogens Category 1.  
Proposed RMMs have started to be put into place by Prevention and Protection Service of 
both hospitals. Very soon after their implementation another monitoring survey is foreseen, 
in order to check their effectiveness and appropriateness. 
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Appendix A  
Exposure modelling exercise 
 
 
 
Before starting with monitoring campaigns, exposure estimation has been carried out 
utilising the software ConsExpo 4.1. The programme, developed by Dutch Institute 
for Public Health and Environment (RIVM) is freely downloadable on the institute 
website. It was created to estimate exposure to chemical substances released by 
consumers’ products, nevertheless having a free-input data mask, it has been 
considered for a preliminary estimate of exposure to formaldehyde in occupational 
settings such as laboratories. Input data of a typical laboratory of Pathology Unit at 
University Hospital Luigi Sacco have been put in the model for the inhalation route, 
as shown in figure A.1. In particular, the “exposure to vapour model” has been 
chosen, which describes a scenario in which a compound evaporates from a surface 
into the room air, for example, spread onto a bench or from a can of product. The 
compound may contain 100% of the product, or be part of a mixture or dilution (as in 
the case of formalin). The concentration in the room air will depend on the amount of 
chemical present in the room, the room size, ventilation of the room air, vapour 
pressure of the compound and the rate at which the compound is released into the 
air (input data, see figure A.1).  
Depending on the information available on physicochemical properties of the 
compound and the use of the product, different modes of release of the compound 
from the product can be selected to calculate the release of the compound into the 
room air. 
The Scenario hypothesis chosen among those proposed for exposure to vapour 
model is “constant rate release”, a second tier scenario. It describes the release of a 
compound with a constant rate over a certain period of time. During this time, the 
compound is simultaneously removed from the air by ventilation of the room.  
The air concentration of the compound at time t is calculated as follows: 
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       when t<tr 
 
and  
 
          when t>tr 
 
where: 
Cair: concentration of compound in the room air [g/m3] 
tr: release time [s] 
Ao: amount of product used  [g] 
wf: weight fraction of the compound in the product [fraction] 
V: room volume [m3] 
q: ventilation rate of the room (number of air changes per time) [1/s] 
 
Hypothesised input data for the Pathology lab: 
A0= 10 (g)   
tr = 30 (min)  
wf = 0.04  
V = 80 m3 
 
Input data inserted try to simulate a plausible routine task which could be pouring a 
certain amount of formalin from a container in dissection room. This operation could 
be repeated for several times per day. Results of the exposure estimation have been 
then compared with level of formaldehyde measured in laboratories, in particular with 
those found in dissection room of University Hospital L. Sacco. Peak values obtained 
from the model are in the same order of magnitude. 
( ) ( )( )rr ttqqtrf
air eeqV
twA
C −−− −×−×
×
= 11
/0
( )qtrfair eqV
twA
C −−×
×
= 1
/0
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Figure A.1 ConsExpo 4.1: input mask for the inhalation model “exposure to vapour” at constant release rate adapted to formaldehyde 
exposure in a pathology lab- 
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Figure A.2 Plotted output data  
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Appendix B 
Results of pilot test 
 
 
 
The methodology followed during pilot test is described in chapter Materials and 
Methods, paragraph 2.2.3. 
In chart B.1 concentration values measured by photo-acoustic monitor and CMS 
sampler during the decay phase vs dilution model (Clausen et al, 1993) are depicted. 
 
Chart B.1 Decay of formaldehyde concentrations measured by two methods vs 
dilution model. 
0.00
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Appendix C 
Results of PCA 
 
 
 
Data obtained from the monitoring at University Hospital L. Sacco have been used to 
perform a PCA. In total, 153 points in time have been measured at Pathology Unit. 
Sixty-one have been excluded from the PCA since measurements were not paired. 
Tables C.1 and C.2 illustrate summary statistics. 
 
Table C.1. Mean, standard deviation and range of the paired measurements 
 
Variable Observations Minimum Maximum Average Standard deviation 
Photo-acoustic 91 -0.124 1.180 0.200 0.221 
CMS 91 -0.100 0.120 -0.036 0.045 
Biocheck-F 91 -0.225 0.000 -0.062 0.057 
 
 
Table C.2. Frequency distribution (counts and percentages) of units by type of task. 
 
Variable Type Frequency % 
1 59 64. 
2 9 9. 
3 4 4. 
4 13 14. 
Operation 
5 6 6. 
 
The biplot is a good representation of the three dimensional matrix since the 
cumulative variability explained by two factors is almost 84% of the total variability. 
The vectors named Bio (Bio check F sampler), CMS (CMS sampler) and Photo 
(photo-acoustic monitor) show in graphic the correlation matrix below: 
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Correlation matrix (Spearman): 
    
Variables Photo CMS BIO 
Photo 1 0.430 0.179 
CMS 0.430 1 0.419 
BIO 0.179 0.419 1 
Bold values are different from 0 at α=0.05 
 
 
Bio-check F values are more positively correlated to CMS than to photo-acoustic 
results. 
The origin of the graph is the TLV-C, therefore points in quadrants I and II of the 
figure have higher results than TLV-C, while points in the third quadrant have levels 
below the TLV-C  for formaldehyde (0.3 ppm). Points in fourth quadrant have higher 
level in Bio-check F results and lower level of CMS and photo-acoustic results.  
 
Figure C.1 biplot 
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In conclusion, looking at the average profiles of the tasks, most of exposure 
determined by any method during task 2 is below the TLV-C, while other tasks have 
different profiles. Tasks 1 and 4 vary along the photo-acoustic measurements, while 
the grouping of tasks seem to follow the classes of Bio-check F measurements 
(task.2 lower followed by task 1, 4 and 3, 5 highest). 
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INDEX-UPRIC Project 
Results of literature review  
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Table D.1 Human and animal studies and in-silico models 
 
a. Human studies, controlled conditions 
 
EFFECT STUDY SUBJECT EXPOSURE OUTCOME COMMENT 
Krakowiak et al. 1998  
 
 
 
 
10 asthmatics with suspected 
respiratory sensitisation to 
HCOH + 10 healthy. 
0.3 ppm (0.5 mg/m3) for 2 
h. 
(+) all subjects reported sneezing, 
itching and congestion. 
Due to infrequent calibrations of 
the exposure chamber, it is 
possible that concentrations 
exceeded 0.5 ppm at some point 
of the study. 
Discomfort (subjective) 
Lang et al, 2008 21 healthy subjects 4h each x 10 dd at different 
concentrations with and 
without peaks (4 x 15 min). 
LOAELs: 
0.3 ppm eye; 
0.5 ppm nose. 
 
NOAELs after adjustments for 
negative affectivity: 0.5 ppm 
constant or 0.3 ppm with 0.6 
peaks.  
 
NOAELs proposed considering 
negative affectivity factors. 
 
Irritation - eye, upper 
airways (objective) 
Lang et al, 2008 21 healthy subjects 4h each x 10 dd at different 
concentrations with and 
without peaks (4 x 15 min). 
LOAEL: 0.5 ppm with 4 x 1ppm 
peaks (eye irritation and blinking)  
NOAEL: 0.5 ppm constant or 0.3 
ppm with 0.6 ppm peaks. 
 
 
 
Krakowiak et al, 1998 10 asthmatics with suspected 
respiratory sensitisation to 
HCOH + 10 healthy. 
0.3 ppm (0.5 mg/m3) for 2 
h. 
(-) no significant pulmonary 
function changes in both groups. 
 
Due to infrequent calibrations of 
the exposure chamber, it is 
possible that concentrations 
exceeded 0.5 ppm at some point 
of the study. 
 
Lang et al, 2008 21 healthy subjects 4h each x 10 dd at different 
concentrations with and 
without peaks (4 x 15 min). 
(-) no significant changes in lung 
function 
NOAEL: 1 ppm 
 
Ezratty et al. 2007 12 subjects with intermittent 
asthma or allergy to pollen. 
0.5 mg/m3 for 1 h in 2 
separated days. 
(-) no significant changes in lung 
function 
NOAEL: 0.5 ppm 
 
 
Pulmonary function 
(FEV1 and FVC) 
Casset et al., 2006 19 asthmatic subjects 0.1 mg/m3 for 30 min. 
 
(+) FEV1 significantly higher after 
formaldehyde exposure (15% vs 
11%, p= 0.046) 
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EFFECT STUDY SUBJECT EXPOSURE OUTCOME COMMENT 
Krakowiak et al, 1998 10 asthmatics with suspected 
respiratory sensitisation to 
HCOH + 10 healthy. 
0.3 ppm  for 2 h. (+) transient increase of the nr. of 
leukocytes and in the permeability 
index of proteins recovered from 
nasal washings from both groups- 
suggesting transient non-specific 
nasal reaction.  
(-) no induction of specific allergic 
responses in either the upper or 
the lower respiratory tract. 
 
Due to infrequent calibrations of 
the exposure chamber, it is 
possible that concentrations 
exceeded 0.5 ppm at some point 
of the study. 
 
 
 
Ezratty et al., 2007 12 subjects with intermittent 
asthma or allergy to pollen. 
0.5 mg/m3 for 1 h in 2 
separated days. 
(-) no significant deleterious effect 
on airway allergen responsiveness 
(no enhanced asthmatic effect) 
A trend to a protective effect of 
formaldehyde was observed. 
Asthma/ 
Hypersensitivity 
Casset et al., 2006 19 asthmatic subjects 0.1 mg/m3 for 30 min. 
 
(+) patients developed an 
immediate bronchial response at 
significantly lower dose of mite 
allergen than after air exposure. 
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b. Human studies, uncontrolled conditions 
 
EFFECT STUDY SUBJECT EXPOSURE OUTCOME COMMENT 
Genotoxicity Orsiere et al, 2006 59 pathology and anatomy 
workers after 1 day-exposure 
(or 8h) 
<0.1-20.4 ppm (sampling 
15 min) 
<0.1 -0.7 ppm (sampling 
8h) 
(+) increased frequency of 
monocentrometric micronuclei 
(MN) in peripheral lymphocytes 
(chromosomal loss).  
(-) no increase in DNA damage 
(repair process or induction of 
lesions) in peripheral lymphocytes. 
 
Aneugenic effect of formaldehyde: 
all call lines derived from HCOH-
induced rat tumours have been 
shown to be aneupoid. 
Results suggest that MN was a 
consequence of spindle 
disturbances (tubulin) and not a 
direct interaction with DNA. 
Histopathological 
changes 
Edling et al., 1988 75 plant workers exposed to 
formaldehyde. 
 
0.1-1.1 mg/m3 with peaks of 
up to 5 mg/m3 
25% of exposed workers had 
changes to nasal mucosa. 
Histological grading showed a 
significantly higher score for nasal 
lesion among exposed. No 
difference btw those exposed to 
wood dust and HCOH and only 
HCOH. 
Authors attribute histopathological 
changes to HCOH alone in the 
0.1-1.1 mg/m3 range 
 
 
Krzyzanowsky M et al. 1990 298 children 5-15 y, 613 adults; 
 
 Increased prevalence rate of 
physician-diagnosed chronic 
respiratory disease (chronic 
bronchitis or asthma) in children 
exposed to HCOH btw 60-140 
ppb. 
Some 10% decrement in PEFR 
was found for concentrations as 
low as 30 ppb (greater effect in 
asthmatic children). Data suggests 
non-negligible respiratory effects 
of prolonged exposure to HCOH 
even below 60 ppb. 
LOAEL 30 ppb 
Greater association of the effects 
was found with ETS and HCOH. 
ETS possible confounder. 
Asthma/ 
Hypersensitivity 
Wilhelmsson B, Holmstrom M, 
1992 
66 plant employees exposed for 
a mean of 10 years 
0.05-0.6 mg/m3 (mean 
0.26. No exposure to 
industrial solvents or 
dust.Ref.group: 36 
community clerks exposed 
to 0.09 mg/m3 
Frequency of atopics in the 
exposed was found low (11%) 
compared to the controls (33%) 
and the general population of UK 
and Scandinavia (30%). An 
hypothesis is that a certain number 
of atopics had left the HCOH-
exposed environment. 
HCOH seems to induce non-
specific hyperreactivity in the 
airways (about 50% of those 
chronically exposed to moderate 
doses) 
Authors believe that HCOH can 
induce, in certain cases, IgE-
mediated type 1 reaction in the 
nose, but in most cases the 
annoying nasal symptoms are due 
to HCOH-induced hyperreactivity 
which can cause problems in 
about 50% of the population 
subjected to long-term exposure at 
levels described in the study. 
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c. Animal studies 
 
EFFECT STUDY SUBJECT EXPOSURE OUTCOME COMMENT 
Cassee, 1996 Rat 1 and 3 day nose-only 
inhalation 6h/day at levels 
of 1.0, 3.2 and 6.4 ppm. 
3dd exp 
-1.0 ppm: no changes  
-3.2 ppm: disarrangement, focal necrosis, 
thickening and desquamation of degenerated 
cells, hyperplasia of basal cells and increased 
number of mitotic figures. Significant increases 
of ULLIs at cross level II (index for cell 
proliferation), increased GPx activities. 
 
Andersen et al. 2008 Rat 1)Exposures to 0, 0.7 2 
and 6 ppm 6h/day, 
5dd/week for 3 weeks. 
2)Single 6h exposure 
adding groups for 15 ppm 
inhalation (compared with 
instillation of 40 µl of 
400mM HCOH solution). 
-0.7 ppm: inflammatory infiltrate observed; 
neither cell proliferation nor histopathology. 
-6 ppm: cell proliferation observed. 
 
Mean daily concentrations of 
HCOH in the inhalation exposures 
were 15-20% less than target 
concentrations. 
The most sensitive responses of 
the epithelium to inhaled HCOH, in 
the range of 0.7-2 ppm, are likely 
to be associated with excursions of 
extracellular HCOH, leading to 
preferential interactions with 
targets on cell membranes or in 
the extracellular components 
Histopathological/bioch
emical changes in nasal 
tissues. 
Nielsen et al, 1999 Mouse Range: 0.2-13 ppm for 30 
min 
RD10: 0.3 ppm (adopted as NOEL). 
 
 
Pulmonary function Nielsen et al, 1999 Mouse Range: 0.2-13 ppm for 30 
min 
RD50s: 3.1-5.3 ppm for decrease in respiratory 
rate. 
RD10: 0.3 ppm (adopted as NOEL). 
 
No bronchocostriction observed at 
the low concentration range. 
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EFFECT STUDY SUBJECT EXPOSURE OUTCOME COMMENT 
Genomic Andersen et al. 2008 Genomic 
benchmark dose analysis was 
performed 
Rat  1)Exposures to 0, 0.7 2 
and 6 ppm 6h/day, 
5dd/week for 3 weeks. 
2)Single 6h exposure 
adding groups for 15 ppm 
inhalation (compared with 
instillation of 40 µl of 
400mM HCOH solution). 
 
Btw 0.7 and 2 ppm: temporal and 
concentration dependent transitions in genomic 
signatures.  
Reduced sensivity by day 15 (Tissue 
adaption). 
U-shaped dose responses were noted in the 
acute study for many genes. 
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d. In-silico models  
 
AUTHOR TITLE/TOPIC POPULATION/STUDY DESIGN MAIN FINDINGS COMMENTS 
(Conolly et al. 
2004) 
Application of the dose-
response computational 
model to humans for the 
prediction of airway cancer 
risk. 
 Switch in additional risk curve between 0.6-0.7 
ppm occurs. 
Direct mutation does not play a significant 
role. Moreover DPX do not accumulate in the 
rat (and humans) with repeated daily 
exposure. 
Additional risk for 80 years of continuous 
environmental exposure to 0.1 ppm of HCOH 
of 10-6 or less for respiratory tract 
carcinogenicity is driven by parameter 
considering DPX, since 0.1 ppm inhaled 
HCOH does not affect cell proliferation 
(cytotoxicity). 
This model is considered (by 
authors themselves) to be based on 
risk-conservative choices. 
(Conolly et al. 
2003) 
Biological motivated 
computational model to 
predict dose-response 
behaviours at exposure levels 
below those at which SCC 
were seen experimentally. (6 
ppm and above) 
 Carcinogenicity of inhaled HCOH in rats 
appears to arise primarily from enhanced cell 
proliferation due to cytotoxic responses rather 
than from a mutagenic potential of the DNA-
protein cross-links. 
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Table D.2. Formaldehyde evaluations and exposure limit proposals 
a. Non-cancer effects 
AUTHOR and 
YEAR HEALTH EFFECTS LOAEL NOAEL UNCERTAINTY FACTORS EXPOSURE LIMIT 
INDEX Project, 
2005 
Nasal and eye irritation, nasal 
obstruction, and lower airway 
discomfort; histopathological nasal 
lesions including rhinitis, squamous 
metaplasia, dysplasia  
LOAEL for nose and 
throat irritation: 0.1 
mg/m3 (WHO, 2000) 
 
30 µg/m3 
(OEHHA, 1999, 
derivation from 
Wilhelmsson and 
Holmstrom, 1992; 
supported by Edling, 
1988) 
10 x 3 
Intraspecies and children 
E.L.: 30 µg/m3 
 
The observed acute effects and endpoints 
are consistent with the pathology seen in 
long-term studies; consequently, no 
distinction has been done between short-
term and long-term ELs.  
Arts, 2008 
 
 The LOAEL of INDEX 2005 was taken from 
WHO report stating that the lowest 
concentration associated with nose and throat 
irritation is 0.1 mg/m3 and 0.6 mg/m3 for eye 
irritation: in volunteer studies when assessed at 
the same time eye irritation was reported at 
levels lower than nose or throat irritation 
(reviewed by Paustenbach, 1997 and Arts, 
2006).  
Eye irritation has been considered the most 
sensitive effect induced by formaldehyde even 
from SCOEL (SCOEL, 2007) ‘it is very difficult, 
if not impossible, to appreciate subjective 
findings of respiratory and eye irritation in 
workers and the general population,’ ‘exposure-
effect concentrations are not exactly known, 
and peak concentrations rather than average 
concentrations might have caused these effects 
(sensory irritation)’ 
‘Although there seems to be 
(some) variation between 
individuals in the reported 
sensory irritation response, this 
certainly was not with a factor of 
10 for inter-individual difference 
within a specific study’. 
These differences may be the 
result of bias, former experience, 
and or perception and affectivity 
rather than due to real differences 
in sensory irritation (Lang et al., 
2008). 
With regards to asthmatic 
vulnerability it has been reported  
in several studies that no 
respiratory effects were observed 
when exposed to levels up to 2 
ppm (Witek et al., 1987, Harving 
et al., 1990; Ezratty et al., 2007). 
Only at concentrations of 3 ppm 
significant changes in lung 
function were reported in 
asthmatic volunteers (Sauder et 
al., 1987). 
The presence of many 
confounders in available studies 
in children such as cigarette 
smoke and other irritant volatile 
organic chemicals, humidity, lack 
of sleep, and the overall 
subjectivity of the studies make it 
difficult id not impossible to 
determine the real causative 
agent. 
It is concluded that an indoor air level of 
0.1 ppm (0.12 mg/m3) formaldehyde, as 
indicated by Appel et al. (2006) can be 
considered a safe and appropriate level. 
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AUTHOR and 
YEAR HEALTH EFFECTS LOAEL NOAEL UNCERTAINTY FACTORS EXPOSURE LIMIT 
Arts, 2008 Eye and nose and throat irritation 
(sensory irritation 
1200 µg/m3 for 
sensory irritation (in 
general)-based on 
Lang 
 5 for intra-species variability 
justified based on the available 
data (Appel et al. 2006). 
No sensitive groups identified. 
It seems that this factor of is 
meant for humans in general, and 
is not worker-specific. Due to a 
more homogeneous population, 
the intra-species factor for 
workers may even be lower. In an 
extensive review on upper 
respiratory tract and ocular irritant 
effects of volatile chemicals a 
higher susceptibility of children 
was not mentioned (Doty et al., 
2004). 
Based on the available data no 
additional assessment factor is 
needed. Appel et al, 2006 
concluded that although in 
children higher internal 
concentrations can be reached 
because of the higher breathing 
rate and an incomplete 
metabolism, there is yet no 
indication that this also true for 
locally acting substances as 
formaldehyde. They therefore 
stated that it is not necessary to 
include an additional child-
assessment factor. No sensitive 
groups identified 
Indoor settings: 0.1 ppm considered safe 
for preventing any adverse effect. 
(‘considered safe realistic and meaningful 
level, while still taking into account the 
carcinogenicity of formaldehyde’). 
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AUTHOR and 
YEAR 
HEALTH EFFECTS LOAEL NOAEL UNCERTAINTY FACTORS EXPOSURE LIMIT 
Paustenbach, 1997 Irritation (eye, nose, throat). 
Sensitization 
Bronchoconstriction  
 
Total of 150 studies evaluated. 
 
1200 µg/m3 for eye. ‘If 
irritation occurs at <1 
ppm the effects 
rapidly subside due to 
accommodation’. 
LOEL: < 360 µg/m3 for 
3-8 h exp. 
LOAEL for 
bronchoconstriction>2 
ppm. 
 
NOEL: 360 (up to 
8h/d exposure) 
 
The panel recognized that there is 
some uncertainty in the margin of 
safety inherent 1.0 ppm per 8 h, 
since the basis is derived from 
relatively small studies of healthy 
volunteers. 
No sensitive groups identified 
‘Repeated exposure may not 
enhance susceptibility to 
formaldehyde’. 
OEL: 360 µg/m3is recommended as TWA  
(would protect nearly all workers except 
perhaps the 95th to 99th percentile person 
from transient eye irritation). 
 
Ceiling:1 ppm  
(‘likely to protect at least 75% and perhaps as 
much as 95% of workers). 
 
For indoor settings levels below 0.1 ppm 
should prevent irritation in virtually all persons. 
Based on the available data the panel 
concluded that although concentrations below 
0.1 ppm in residential setting have been 
reported to cause minor irritant effects in 
humans, based on the data obtained in 
volunteer studies, it is likely that this level of 
response was attributable to other 
environmental factors, the background 
incidence of eye irritation, self-selection bias, 
or the effects of interviewer interaction. 
IAQ – WHO (2000) Nose and throat irritation in humans 
after short-term exposure  
100 µg/m3 
 
The lowest 
concentration that has 
been associated with 
nose and throat 
irritation in humans 
after short-term 
exposure is 10, 
mg/m3, although 
some individuals can 
sense the presence of 
formaldehyde at lower 
concentrations. 
 
  100 µg/m3 (30-minute average)  
 
* although some individuals can sense the 
presence of FA at lower concentrations  
 
* exposure level at which there is a negligible 
risk of upper respiratory tract cancer in 
humans. 
HEALTH CANADA: 
Proposed 
residential 
indoor air quality 
guidelines 
for formaldehyde 
(2005) 
Short-term Effects - irritation of the 
mucosa of the upper respiratory 
tract and the eyes. (Kulle et al. 
1993) 
 
 
Chronic Effects Other Than Cancer 
hospitalization for asthma in 
children  
(Rumchev et al. 2002), 
1230 µg/m3 
 
615 µg/m3 
 
 
 
 
50 µg/m3 
10  
 
 
 
 
123 µg/m3 - (1-hour averaged) 
 
 
 
 
50 µg/m3 - (8-hours averaged) 
  
* development of allergic sensitization and/or 
asthma is biologically plausible as it is 
consistent with observations in animals. 
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AUTHOR and 
YEAR 
HEALTH EFFECTS LOAEL NOAEL UNCERTAINTY FACTORS EXPOSURE LIMIT 
* the risk of cancer associated with FA levels 
sufficiently low to prevent irritation and 
inflammatory responses appears therefore to 
be negligible. 
AFSSET, French 
IAGV (2007) 
 
Acute: irritation of the respiratory 
tract and infraclinical inflammation 
(ATSDR 1999 evaluation based on 
Pazdrack et al. 1993.) 
 
Chronic: histopathological lesions 
in the nose  
(ATSDR 1999 evaluation based on  
Holmstrom et al., 1989) 
500 µg/m3 
 
 
 
 
300 µg/m3 
 10 
 
 
 
 
10 x 3 
 
intra-species variability and use of 
a LOAEL 
50 µg/m3 (2 hours).  
* also protecting against other suspected 
effects, such as respiratory function 
impairment. 
 
10 µg/m3 (for long-term exposure) 
RIVM, guideline 
values for the indoor 
environment (2007) 
RIVM 1995: eye, throat and nose 
irritation in humans 
 
 120 µg/m3 100 used in 1995 for TCA: 1 
target value in air  - annual 
average. The question arises how 
much need there is for the 
relatively large safety margin 
(factor 100) used in 1995.  There 
is a large variation between 
individuals in the human 
population in terms of the 
sensitivity to sensory irritation by 
FA. Some individuals only 
experience a reaction at 
concentrations exceeding 1 
mg/m3while others are sensitive 
to significantly lower 
concentrations;  
some susceptible individuals may 
experience discomfort at lower 
concentrations. It is 
not possible to give a reliable 
estimate of the concentration 
below which this will not occur. 
In conclusion, given the minor 
critical effect (sensory irritation), it 
would appear that the safety 
factor applied in 1995 might be 
rather high. 
Maximun permissible risk:  
 
120 µg/m3 as the 30 minute average  
 
10 µg/m3as the annual average.  
 
 
* this is with the proviso that certain sensitive 
individuals may suffer irritation even at levels 
below the MPR 
OEHHA, 2008 Eye irritation 1200 µg/m3 
Benchmark 
concentration (as 
BMCL05) : 0.44 ppm 
On eye irritation 
(based on Kulle et al 
1987) 
600 µg/m3 -factor of 10 for toxicodynamics 
(intraspecies), for potential in 
asthma exacerbation, in children. 
The factor is inclusive of 
exacerbated effects on contact 
lens wearers 
Acute REL 55 µg/m3 (44 ppb) 
 
A possible mechanism explaining the 
association HCOH exposure-asthma is given. 
Genetic variation among individuals in the 
alcohol dehydrogenases (as ADH3-which is 
GSNOR) affects individual responses to 
HCOH. Unexpected variability was observed 
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AUTHOR and 
YEAR 
HEALTH EFFECTS LOAEL NOAEL UNCERTAINTY FACTORS EXPOSURE LIMIT 
for bronchoconstriction and airway 
hyperreactivity. Although human studies 
investigating asthma, atopy or 
hypersensitisation due to HCOH exposure are 
not entirely consistent with each other 
(potential for confounding in each), taken 
together they suggest that children may be 
more sensitive to HCOH toxicity than adults. 
 Obstruction and discomfort, lower 
airway discomfort, eye irritation. 
 
 90 µg/m3 
Based on 
Wilhelmsson and 
Holstrom 1992 
(exposure of the 
reference group) 
-factor of 10 for toxicodynamics 
(intraspecies), for potential in 
asthma exacerbation, in children. 
8-hour REL 9 µg/m3 (7 ppb)  
 
 Increased pulmonary resistance 1200 µg/m3 
 
0.59 ppm 
based on 
Swiecichowski et al, 
1993 (guinea pigs) 
Cumulative uncertainty factor: 60 
- Interspecies factor of 6 for 
toxicokinetic (adjustment to 
Human Equivalent Concentration) 
-factor of 10 for toxicodynamics 
(intraspecies), for potential in 
asthma exacerbation, in children. 
8-hour REL 10 µg/m3 (8 ppb) 
 Obstruction and discomfort, lower 
airway discomfort, eye irritation. 
 
 90 µg/m3  
Based on 
Wilhelmsson and 
Holstrom 1992 
(exposure of the 
reference group) 
-factor of 10 for toxicodynamics 
(intraspecies), for potential in 
asthma exacerbation, in children. 
Chronic REL 9 µg/m3 (7 ppb)  
 
 Asthma symptoms (cough, 
shortness of breath, wheeze, 
trouble breathing) 
60 µg/m3 
 
30 µg/m3 (lower limit 
of NOAEL range) 
Based on Rumchev et 
al., 2002 (asthmatic 
children) 
Intraspecies factor of 10  (3.16) 
for potential toxicodynamic 
variability (inter-individual 
variation) 
Chronic REL 10 µg/m3 (8 ppb)  
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b. Considering carcinogenic effects  
AUTHOR and 
YEAR 
HEALTH EFFECTS LOAEL NOAEL UNCERTAINTY FACTORS EXPOSURE LIMIT 
Appel, 2006 \ 
 
240 µg/m3 
A slight sensory irritation 
response can be observed 
at concentrations of 0.2 – 
0.3 ppm and ocular and 
upper respiratory tract 
sensory irritation is not 
present below 0.1 ppm 
120 µg/m3  120 µg/m3 (0.1 ppm) 
 
* Since 0.1 ppm is more than 10 times below 
the threshold level observed for cytotoxic 
damage in the nasal mucosa, this level seems 
to protect the whole population with regard to 
the carcinogen. 
Arts, 2006 Sensory irritation (eye, nose and 
throat)-volunteer studies; 
Nasal injury - animals. 
Carcinogenicity - animals, 
population studies. 
LOAEL for sensory 
irritation (humans): 1 ppm 
for eye, and 2 ppm for 
nasal and 3 ppm throat.  
 
Threshold for increased 
nasopharyngeal cancer 
risk in humans: 4 ppm 
(Hauptmann et al., 2004).  
Formaldehyde considered 
carcinogenic at cytotoxic 
levels only, i.e. levels at 
which sustained 
regenerative epithelial 
proliferation is observed ≥ 
6 ppm in animals. 
 
Animals: 
NOAEL for nasal injury: 1 
ppm 
LOAEL for epithelial 
hyperplasia and 
squamous metaplasia: 2 
ppm 
 
BMD analysis performed 
on Andersen and Mohave 
1983, Kulle 1993, Kulle et 
al, 1987.  
For 10% extra risk for mild 
eye irritation is accepted, 
0.56 ppm (C.I. 95%) would 
be acceptable. 
At level of 1 ppm: 
-56% (C.I. 95%) 
experiences ‘slight 
discomfort’ after 2.5 h. 
 No sensitive groups identified 
(no asthma correlation, nor 
enhanced effects on asthmatic 
subjects). 
Airborne levels of formaldehyde below 1 ppm 
seem low enough to protect workers against 
nasal tissue damage, consequently against 
the potential risk of nasal cancer 
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AUTHOR and 
YEAR 
HEALTH EFFECTS LOAEL NOAEL UNCERTAINTY FACTORS EXPOSURE LIMIT 
-0% experiences 
‘discomfort’ 
-30% (C.I. 95%) 
experiences ‘mild eye 
irritation’ 
9.5% (C.I. 95%) 
experiences ‘moderate 
eye irritation’ 
 
 
 
c. Occupational exposure limits  
AUTHOR and 
YEAR 
HEALTH EFFECTS LOAEL NOAEL UNCERTAINTY FACTORS EXPOSURE LIMIT 
Occupational 
exposure limit for 
Quebec workers. 
(Noisel, Bouchard 
and Carrier 2007) 
Irritation can cause an irritant-
induced asthma reaction and 
induce cytotoxicity that can act as a 
cancer promoter. 
The experimental data show that 
there was no difference in the 
proportion of individuals 
experiencing effects in groups 
exposed to FA concentrations 
LOAEL : 1 ppm 
Benchmark concentration 
(as BMCL05) : 0.44 ppm 
on eye irritation based on 
Kulle et al 1987 
NOAEL : 0.5 ppm 
 
asthmatics did not appear to be 
more sensitive to irritation at 
FA concentrations below 3 
ppm . 
the risk of irritating effects would be negligible 
for airborne formaldehyde concentrations 
below 0.75 ppm.  
SCOEL: 
Occupational 
exposure limits (Bolt 
and Huici-Montagud 
2008) 
Subjective symptoms of eye 
irritation (based on Lang, 2008) if 
the personal trait of negative 
affectivity was treated as a co-
variable. 
 360 µg/m3 The TWA-OEL of FA should be 
set at or 
below the NOAEL for sensory 
irritancy of the eye. In view of 
the limited number of persons 
that can be examined in a 
laboratory volunteer study, the 
exclusion of particularly 
sensitive persons with negative 
affectivity appears 
problematic. 
480 µg/m3- 15min-STEL 
This STEL is set below the threshold for 
objective eye irritation, as outlined by Lang  
At these levels, no systemic effect of 
formaldehyde is to be expected 
 
240 µg/m3 - 8h-TWA 
This especially considers possible 
interindividual differences in susceptibility to 
irritation by formaldehyde  
 
Additional classification: skin sensitizer. 
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d. Outdoor exposure limits  
AUTHOR and 
YEAR HEALTH EFFECTS LOAEL NOAEL UNCERTAINTY FACTORS EXPOSURE LIMIT 
RA for the general 
population in 
Japan(Naya and 
Nakanishi 2005) 
Histopathological changes (i.e., loss 
of cilia, goblet cell hyperplasia, and 
cuboidal and squamous cell 
metaplasia) in the nasal cavity 
(Holmstrom et al., 1989) 
50 µg/m3 
The lowest concentration 
of 0.04 ppm in the study of 
Holmstrom et al. is 
considered to be nearly 
equal to NOAEL; 
 
3 
for human LOAEL. 
  
12 µg/m3 
Reference value of FA in atmosphere 
(outdoor air) for Japanese general population is 
recommended 
 
  
 
 
 
